根據規則424(b)(5)提交

註冊 編號 333-281578

招股書補充資料

（根據2024年9月9日的招股說明書）

15,625,000股本次發行後的普通股份受益所有權

我們根據本補充資料書及隨附的招股說明書向投資者提供了15,625,000股普通股，每股面值爲0.0001美元，股價爲每股0.096美元。

我們的普通股在納斯達克股市LLC上交易，股票代碼爲「JTAI」。納斯達克資本市場”。我司普通股2024年10月17日的最新報價爲每股0.0969美元。我們的主要執行辦公室位於內華達州拉斯維加斯，10845 Griffith Peak Drive， 200套房，郵編89135。

截至2024年10月17日，我們未直系關係人持有的普通股的總市值約爲$20,074,720，該金額根據未直系關係人持有的97,402,812股普通股計算，每股價格爲$0.2061，即截至2024年8月23日我們的普通股在納斯達克上的收盤價，在過去六十(60)天的交易週期內，公司的普通股的最高收盤價。根據Form S-3的I.b.6通用指示，我們不會在公開的首次發行中銷售其在本招股說明書中描述的證券，其價值超過其非關聯人持有的普通股總市值三分之一（1/3），只要非關聯人持有的普通股總市值保持在7500萬美元以下。在本招股說明書通過前十二(12)個月，包括並且包含本招股說明書的日期，我們依據Form S-3的I.b.6通用指示已提供和銷售了約合計$2,400,000的證券的總毛收入。

投資我們的證券涉及高度風險。您應仔細查閱招股書第12頁開頭的「Risks」一節和招股書的任何修訂或補充的類似節。風險因素本招股說明書補充資料中從第S-4頁開始包含的「」，以及被引入本招股說明書補充資料中的其他文件中類似標題下的內容。

(1) 請查看“分銷計劃” 了解我們將支付給Maxim Group LLC的補償的詳細信息（"Maxim”或「賣方」宣傳代理”).

證券交易委員會和任何州證券委員會均未批准或未否決這些證券，並未確定本招股說明書補充是否真實或完整。任何相反的陳述都是一種犯罪行爲。

股份將於2024年10月21日左右準備交付。

唯一的承銷代理

MAXIM GROUP LLC

本拓展說明書補充的日期爲2024年10月21日。

目錄

招股書補充資料

招股書

關於本招股說明書補充

此文件是我們向證券交易委員會提交的註冊聲明的一部分SEC使用「貨架」註冊流程，由兩個部分組成。第一部分是本招股說明書，描述了本次發行的具體條款。第二部分是附屬招股說明書，提供更一般的信息，其中一些可能與本次發行無關。通常情況下，當我們僅提到「說明書」時，指的是兩部分合並在一起的文件。本招股說明書可能會新增、更新或更改附屬招股說明書及其引用的文件中的信息

如果本招股說明書補充的信息與隨附的招股說明書或任何已在本招股說明書補充日期之前向SEC提交的文件不一致，您應依賴於本招股說明書補充。你需要閱讀並考慮本招股說明書補充和隨附招股說明書中包含或通過引用的所有信息，在作出投資決定時。本招股說明書補充、隨附招股說明書和通過引用的文件中都包含了關於我們、所發行證券及其他您在投資我們證券前應了解的重要信息。你還應該閱讀並考慮本招股說明書各部分中我們已經引用的文件中的信息，這些部分標爲“信息的參考”和“您不應在任何禁止發行或邀請的轄區內或不具備發行或邀請資格的人員那裏發行本招股說明書所涵蓋的證券。.”

你應該僅依靠本增補條款、附屬招股說明書、本處或其中明確或被認定已合併的文件以及我們或者由我們代表編制的任何自由書面招股說明書。我們和Maxim並未授權任何人向您提供超出或與本增補招股說明書和附屬招股說明書中所包含或合併引用的信息不符的信息。如果有人向您提供不同或不一致的信息，您不應該依賴它。我們和Maxim不在任何不允許該報價或銷售的司法管轄區內提供出售這些證券。本增補招股說明書並非構成，並且不得用來與本增補招股說明書中的任何人在任何不允許前述人員進行此類報價或徵求意向的司法管轄區內的證券有關聯這一報價或買入要約的交易。

您不應假設本招股說明書、隨附的招股說明書或任何自由書面招股說明書中包含的信息在除本招股說明書或隨附的招股說明書或任何自由書面招股說明書之外的任何日期都是準確的，或者在無論本招股說明書和隨附的招股說明書的交付時間或任何我們證券的銷售時間之前，納入參考的文件的日期不管是多久，我們的業務、財務狀況、流動性、經營業績和前景自那些日期以來可能已經發生了變化。

我們另外注意到，在任何文件的協議中，該文件作爲引用文件被併入本招股書補充文件或相應招股書所引用的文件中，由我們所做出的陳述、保證和承諾僅受益於該文件的各方，包括在一些情況下，爲了在該文件各方之間分配風險的目的，不應被視爲向您提供的陳述、保證或承諾。而且，此類陳述、保證或承諾僅在所做陳述時準確。因此，不應將此類陳述、保證或承諾視爲準確表達我們目前的事務狀況。

除非在本招股說明書補充中另有說明或上下文另有要求，所有提到的「我們」，「我們」，「我們的」，「公司」和「Jet.AI」均指Jet.AI Inc.及其合併子公司。當我們提到「您」，我們指的是適用系列證券的潛在持有人。

本招股說明書補充材料及隨附的招股說明書以及在此處和其中通過引用的文件包括我們或其他公司擁有的商標、服務標記和交易名稱。所有在本招股說明書補充材料或隨附的招股說明書中包含或引用的商標、服務標記和交易名稱均爲其各自所有者的財產。僅爲方便起見，本招股說明書補充材料或隨附的招股說明書中提到的商標和交易名稱，包括標識、藝術作品和其他視覺展示，可能出現時沒有®或Tm符號，但此類引用並不意圖在任何方式上表明，他們各自的所有者將不會根據適用法律的最大範圍主張其權利。我們並不打算使用或展示其他公司的商業名稱或商標以暗示與其他公司的關係，或暗示其他公司對我們的認可或贊助。

本招股說明書補充和隨附的招股說明書以及在此處和那裏通過參考併入的文件均包括我們基於我們管理層對我們業務所在市場的了解和經驗以及從各種來源獲取的信息，包括公開信息、行業報告和出版物、調查、我們的客戶、分銷商、供應商、交易和業務組織以及我們經營市場中的其他聯繫人。在某些情況下，我們並未明確指出此數據來源。管理層估計數據源自獨立行業分析師和第三方來源發佈的公開信息，以及我們內部研究的數據，並基於我們對這些數據的審查和我們對該行業和市場的了解而做出的假設，我們認爲這些假設是合理的。

在提供這些信息時，我們基於這些數據和其他類似來源以及我們對我們分發產品市場的了解和迄今爲止的經驗，做出了一些我們認爲是合理的假設。市場份額數據可能會發生變化，受原始數據的可用性、數據收集過程的自願性質以及其他在市場份額統計調查中固有的限制的限制。此外，客戶偏好可能會發生變化。

在美國境外的任何司法管轄區，均沒有采取任何行動允許公開發行證券或者持有或者分發此補充招股說明書或附帶招股說明書。在美國境外的司法管轄區取得此補充招股說明書或附帶招股說明書的人員，必須自行了解並遵守與此招股的約束和此補充招股說明書或附帶招股說明書的分發有關的任何限制規定適用於該司法管轄區。

招股說明書補充文件摘要

此摘要突出了此招股說明書補充或附屬招股說明書中其他地方包含或引用的信息。此摘要並不完整，也未包含您在做出投資決定時應考慮的所有信息。在投資我們的普通股之前，您應仔細閱讀整個招股說明書補充、附屬招股說明書以及此招股說明書補充和附屬招股說明書中引用的文件，包括"風險因素"、"管理層對財務狀況和經營結果的討論"、我們的合併財務報表以及在此招股說明書補充和附屬招股說明書中引用的相關附註，以及此招股說明書補充和附屬招股說明書所屬的註冊聲明中的陳述書和附屬資料。

公司概覽

Jet.AI公司成立於2018年6月4日，位於內華達州拉斯維加斯。2023年8月10日，我們完成了一項業務合併，使Jet Token公司與特殊目的收購公司Oxbridge Acquisition Corp.合併，在該交易的背景下，合併公司更名爲Jet.AI公司。

我們 是一家開發創新人工智能的私人包機公司（”AI”) 促進的技術 通過我們的 iOS 和安卓包機預訂應用程序 CharterGPT 訪問私人飛機旅行 (”CharterGPT”）， 還有我們的 B20軟件平台，它提供了一套軟件即服務（”SaaS的”) 我們提供的產品 飛機所有者和運營商。我們努力通過利用，簡化和增強運營商和客戶的航空體驗 先進的自然語言處理和先進的車隊物流優化。

我們的 商業戰略將部分飛機所有權計劃和航空飛機會員卡的概念與人工智能創新相結合。我們的 CharterGPT 應用程序使用自然語言處理和機器學習來改善私人飛機預訂體驗，即 通過 CharterGPT 通過我們的應用程序編程接口直接連接（”API”) 到 Avinode， 私人航空業最大的包機服務集中式數據庫之一。CharterGPT 接收用戶的請求 對於私人飛機旅行，將用戶與已發佈飛機租賃的私人包機運營商聯繫起來，顯示各種各樣 從Avinode平台上列出的數千架飛機清單以及定價中提取的各種價格的包機預訂選項 爲我們自己的四架飛機組成的機隊，並促進用戶和運營商之間的溝通、合同交換和付款 飛機最終選擇旅行。

我們的 Jet.人工智能 控件平台當前包含以下saas-雲計算產品:

目前我們擁有五架飛機，包括三架HondaJet HA-420飛機（「HondaJet Elites」），一架Citation CJ4 Gen 2和一架King Air 350i。這三架HondaJet Elites由Cirrus管理、運營和維護，根據《執行飛機管理和包機服務協議》的規定，符合所有適用的FAA法規和認證要求。我們艦隊中的Citation CJ4 Gen 2和King Air 350i由客戶擁有，並通過我們的OnBoard計劃進行管理，該計劃允許飛機所有者在完成特定的FAA認證和要求後將飛機貢獻給我們的包機和噴氣卡存貨。HondaJet Elites

我們爲本田噴氣機精英飛機提供以下方案：

除了爲會員、部分所有者和第三方包機客戶提供服務，我們的HondaJet Elites還可用於處理經紀包機的意外取消或延誤。我們能夠保持一支隨時可用的飛機機隊，以填補第三方包機服務，使我們具有比競爭對手更可靠的競爭優勢，併成爲潛在客戶的吸引點。

企業信息

我們的網址是www.jet.人工智能通過我們的網站包含或可訪問的信息未納入本招股說明書補充，並不屬於本招股說明書補充的一部分。

我們的普通股在納斯達克上市，股票代碼是「JTAI」。我們的首席執行官辦公地址位於內華達州拉斯維加斯市格里菲思皮克大道10845號200室，電話號碼爲（702）747-4000。

發行

除非另有說明，本招股說明書補充中所有信息均基於以下情況：

風險因素。

投資我們的證券涉及高風險。 請參閱我們截至2023年12月31日年度報告中「風險因素」下的風險因素，該報告已提交給證監會，以及後續提交給證監會的報告中確定的風險因素，包括我們截至2024年6月30日季度報告中的風險因素，這些報告已被納入本招股說明書。 在您投資我們的證券之前，您應仔細考慮這些風險，以及我們在本招股說明書和附帶招股說明書中包括或納入的其他信息。 我們描述的風險和不確定性不是我們公司所面臨的唯一問題。 我們目前不知道的其他風險和不確定性，或者我們目前認爲不重要的不確定性，也可能影響我們的業務運營。 這些風險中的任何一種發生都可能導致您失去全部或部分投資。 風險討論包括或涉及前瞻性陳述； 您應閱讀本招股說明書其他地方討論的前瞻性陳述的資格和限制解釋。

與本次發行有關的風險

我們可能會將這次發行的淨收益分配到股東可能不同意的地方。

我們目前打算將此次發行所得的淨收入（如有）用於一般企業用途，包括開發和推廣我們的saas-雲計算產品、飛機採購、研發、一般管理費用、許可或技術收購、運營資本支出和資本支出。此外，我們計劃利用此次發行的一部分淨收入贖回A系列優先股和A-1系列優先股，包括任何應付的應計利息和/或補償。我們也可能利用淨收入償還任何債務和/或投資於或收購補充性業務、產品或技術，儘管截至本招股說明書日期，我們目前並無關於此類投資或收購的任何承諾或協議。此次發行淨收益的預期使用反映了我們根據當前計劃和業務狀況的意圖。我們實際支出的金額和時間可能會根據諸多因素髮生顯著變化。由於會影響我們使用本次發行所得的資金的因素數量和可變性，最終利用將可能與當前預期用途大不相同。因此，我們將保留自行決定如何分配此次發行淨收益並可能以並不一定提升我們營運業績或增進普通股價值的方式使用資金。請參閱名稱爲“使用所得款項詳見「 」以了解更多信息。

股東可能會立即和大量地經歷攤薄。

根據每股普通股的發行價格$0.096，購買者將有效承擔每股約$0.088的淨有形賬面價值攤薄，即發行價格約爲8.1%的股份。 此外，您可能會因我們普通股的發行而進一步蒙受攤薄，在優先股權或期權行使後發行的普通股份。請參閱「」部分，以獲取有關發行給新投資者的攤薄的更詳細描述。稀釋查看每股普通股的發行價格$0.096，購買者將有效承擔每股約$0.088的淨有形賬面價值攤薄，即發行價格約爲8.1%的股份。 此外，您可能會因我們普通股的發行而進一步蒙受攤薄，在優先股權或期權行使後發行的普通股份。請參閱「」部分，以獲取有關發行給新投資者的攤薄的更詳細描述。

您 可能會因未來股權發行而面臨未來稀釋。

爲了籌集額外資金，我們將來可能以與本次發行價格不同的價格，發行額外的普通股或其他可轉換爲或可交換爲我們的普通股的證券。我們可能會以每股價格低於本次發行中任何投資者支付的每股價格的價格，出售股票或其他證券，併購買未來股票或其他證券的投資者可能擁有優於現有股東的權利。我們出售額外的普通股、或可轉換爲或可交換爲普通股的證券的每股價格，在未來交易中可能高於或低於本次發行中任何投資者支付的每股價格。

公司業務相關的風險

如果未能成功籌集到額外資金，公司可能無法繼續經營其業務，因此可能無法作爲一個持續經營實體。

公司依賴自身經營的資金、融資安排的收入和額外籌款，以維持持續經營。公司持續遭受來自經營的損失，並有顯著積累虧損。由於這些經營損失的持續存在、經營活動現金流量爲負和需要額外資本，公司是否能夠繼續作爲持續經營主體存在存疑。因此，我們獨立的註冊會計師事務所在報告公司截至2023年12月31日的年度審計財務報表中包括了一段表達對於公司能夠繼續作爲持續經營主體存在存疑的解釋性段落。財務報表已按照美國通用會計準則編制，其假設公司將繼續作爲持續經營主體存在。公司的財務報表不包含如果公司無法繼續作爲持續經營主體存在可能產生的任何調整。不能確保管理層能否獲得可接受公司的資本的充足數量。如果公司無法獲得足夠額外資本，公司可能需要減少其計劃開發和運營的近期範圍，這可能會延誤公司業務計劃的實施，並影響其業務、財務狀況和營運結果。在這種情況下，公司可能不得不顯著減少其業務或推遲、縮減或終止一個或多個產品的開發，尋求替代融資安排，宣佈破產或完全終止業務。

如果公司無法內部或外部融資其飛機或產生足夠的資金支付給外部融資來源，公司可能會失敗。

根據航空行業的慣例，公司依賴外部融資來收購飛機，並且未來可能需要額外融資以擴大其機隊。如果公司無法產生足夠的營業收入或其他資金來支付租賃安排，出租方可能會收回飛機，這將對公司的業務和聲譽造成重大不利影響。此外，如果公司無法出於任何原因（包括與公司的業務或前景以及更廣泛經濟有關的原因）獲得未來飛機的外部融資，公司可能無法增長和/或生存。

公司可能沒有足夠的資本需求，可能需要籌集更多資金，後續融資條件可能會對您的投資產生不利影響。

公司預計隨着發展壯大，將需要借款以支持其運營資金需求。利率期貨仍保持在歷史高位，並且對於以有利條件獲取信貸而言，環境相當嚴峻。如果公司在需要時無法獲得信貸，公司可能會發行債務或股本證券以籌集資金，調整其增長計劃或採取其他舉措。債務證券利息可能會增加成本並對經營業績產生負面影響，可轉換債務證券可能導致稀釋你對公司的權益。如果公司無法以有利條件找到額外資金，那麼公司可能會選擇停止銷售活動。在這種情況下，要想獲得投資回報的唯一資產可能就是公司的知識產權。即使公司不被迫停止銷售活動，但資金缺乏可能導致公司的表現低於預期，從而對你的投資價值造成不利影響。

公司的業務和聲譽依賴於，並將繼續依賴第三方。

公司一直依賴第三方應用程序開發者來開發其應用程序的初期版本，並且公司可能一直依賴第三方開發任何新的或修訂的應用程序的部分。 公司不再依賴第三方應用程序開發者，取而代之的是公司依賴內部開發以及由公司首席技術官監督的自由承包商。 公司打算繼續建設其內部開發團隊，並逐漸減少其對外部承包商進行應用程序開發的依賴。 如果應用程序的進一步開發出現延遲或問題，可能會導致困難，包括但不限於以下情況：

公司還預計將在其現有營運夥伴Cirrus大力支持下，維護和操作公司租賃的飛機用於包機服務，當客戶通過其平台預訂航班時，公司將依賴第三方運營商。公司和Cirrus都積極地爲公司的飛機預訂包機服務。Cirrus通過其24小時包機部門預訂包機，公司通過其應用程序預訂包機。這些第三方未能正確履行這些角色可能導致公司聲譽受損、客戶流失、可能的訴訟和其他成本。公司也可能在工作中遇到延遲、缺陷、錯誤或其他問題，這可能對其業績和實現盈利能力產生不利影響。

公司可能沒有足夠的所有基金類型來維持業務，直到盈利爲止。

公司可能無法準確預測資金的使用速度以及這些資金是否足以使業務盈利。

航空 業務往往受到影響遠非他們所控制的因素，包括：機場空中交通擁堵；機場航班時刻限制； 空中交通管制效率低下；自然災害；惡劣天氣條件，如颶風或暴風雪；安全措施的增加和變化 ；變化的監管和政府要求；旅行相關稅收新設立或變更；或疾病爆發； 其中任何一項都可能對公司的業務、運營結果和財務狀況產生重大不利影響。

喜歡 其他航空公司，該公司的業務受到其無法控制的因素的影響，包括空中交通擁堵 機場、機場時段限制、空中交通管制效率低下、自然災害、惡劣天氣條件、增加和 更改安全措施、不斷變化的監管和政府要求、新的或變更的旅行相關稅收或疫情 疾病的。導致航班延誤的因素會使乘客感到沮喪，增加運營成本並減少收入，這反過來可能會 對盈利能力產生不利影響。在美國，聯邦政府單獨控制所有美國空域和航空運營商 完全依賴於美國聯邦航空管理局（”聯邦法奧”) 在安全的環境中操作該空域， 高效且負擔得起的方式。由美國聯邦航空局運營的空中交通管制系統在管理不斷增長的空中交通管制系統方面面臨挑戰 對美國航空旅行的需求。美國空中交通管制員經常依賴過時的技術，這些技術通常會使系統不堪重負 迫使航空運營商使用效率低下的間接航線，導致延誤和運營成本增加。此外，還有 目前正在國會面前提出的可能導致美國空中交通管制私有化的提案 系統，這可能會對公司的業務產生不利影響。

極端的天氣條件和自然災害，例如颶風、冬季暴雪或地震，可能導致航班取消或顯著延誤。由於極端天氣條件或自然災害、空中交通管制問題或低效、安防半導體問題或其他因素導致的取消或延誤，可能對公司產生比競爭對手更大的影響，後者可能能夠更快地從這些事件中恢復，因此可能對公司的業務、運營結果和財務狀況產生重大不利影響，其程度可能超過其他航空公司。乘客流量的普遍減少可能對公司的業務、運營結果和財務狀況產生重大不利影響。

飛機的運營受到各種風險的影響，未能保持良好的安全記錄可能對我們獲取和保留客戶產生不利影響。

飛機的運營受到各種風險的影響，包括災難性災難、墜機、機械故障和碰撞，可能導致生命、人身傷害和/或財產和設備損失。公司未來可能發生事故。這些風險可能危及其客戶、人員、第三方、設備、貨物和其他財產的安全（包括公司和第三方的財產），以及環境。如果發生任何這些事件，公司可能會遭遇營業收入損失、客戶合同終止、更高的保險費率、訴訟、監管調查和執法行動（包括可能暫停公司機隊飛行和暫停或吊銷其運營許可）、以及對聲譽和客戶關係的損害。此外，如果發生公司運營或包機的飛機事故，公司可能需要承擔相應的損失，這可能涉及受傷乘客和罹難乘客的索賠。無法保證公司在發生此類損失時所能獲得的保險覆蓋金額足以彌補此類損失，或者公司不會被迫承擔此類事件造成的重大損失，無論其保險覆蓋情況如何。

此外，任何飛機事故或事件，即使完全投保，無論涉及公司還是其他私人飛機運營商，都可能導致公衆認爲公司比其他私人飛機運營商不安全或不可靠，從而導致客戶失去信心並轉向其他私人飛機運營商或其他運輸方式。此外，任何飛機事故或事件，無論涉及公司還是其他私人飛機運營商，也可能影響公衆對行業安全的看法，從而降低客戶的信任度。

公司需要承擔相當大的成本來維護其（i）安全計劃、（ii）培訓計劃和（iii）飛機機隊的質量。公司無法保證這些成本不會增加。同樣，公司無法保證其努力會提供足夠水平的安全性或可接受的安全記錄。如果公司無法保持可接受的安全記錄，公司可能無法保留現有客戶或吸引新客戶，這可能對其業務、財務狀況和運營成果產生重大負面影響。

航空行業的飛行員供應有限，可能對公司的運營和財務狀況產生負面影響。 勞工成本的增加可能對公司的業務、運營結果和財務狀況產生不利影響。

公司的飛行員必須符合嚴格的飛行員資格和機組成員飛行訓練標準，其中包括飛行員的最低飛行時間要求和規定的嚴格規則以減少飛行員的疲勞。這些要求的存在有效限制了合格飛行員候選人的供應，增加了飛行員薪水和相關勞動成本。飛行員短缺將要求公司進一步增加勞動成本，這將導致其收入的實質性減少。此類要求還影響飛行員的排班、工作時間和公司運營所需飛行員的數量。

此外，如果無法及時培訓飛行員，公司的運營和財務狀況可能會受到負面影響。由於行業板塊內合格飛行員短缺，受美國聯邦航空局資質標準下的飛行小時要求以及其他行業參與者的招聘需求導致，飛行員培訓時間明顯延長，飛行模擬器、教練和相關培訓設備的供應出現緊張。因此，公司飛行員的培訓可能無法以成本效率或足夠及時的方式完成，以支持公司的運營需求。

飛行員流失可能對公司的運營和財務狀況產生負面影響。

近年來，公司發現飛行員的流失率出現了顯著波動，這是由於其他行業參與者提高飛行員工資和獎金以及貨運、低成本和超低成本航空公司的增長。如果流失率高於替代飛行員的數量，公司的運營和財務業績可能會受到重大不利影響。

公司由於維護工作而暴露於運營中斷。

公司的機隊需要定期維護工作，可能會造成業務中斷。公司無法及時進行維護和修理可能導致其飛機利用率降低，對其業務、財務狀況和運營結果產生不利影響。偶爾，機身製造商和/或監管機構要求針對特定機隊進行強制或建議性修改，可能意味着需要停飛特定類型的飛機。這可能會導致公司的業務中斷，並對公司造成重大成本。此外，隨着公司的飛機基數增加，維護成本可能會潛在增加。

法律或法規的變化，或者未能遵守任何法律或法規，可能會對我們的業務、投資和經營結果產生不利影響。

我們需遵守由國家、區域和地方政府制定的法律法規。公司的業務受到FAA、運輸安全管理局以及"了解您的客戶"義務和其他法律法規的重大監管。關於公司產品或服務銷售的法律法規可能會發生變化，如果發生變化，公司產品或服務的銷售可能不再可行或盈利。此外，我們還需遵守特定的證券交易委員會和其他法律要求。遵守和監督適用的法律法規可能是困難的、耗時的和昂貴的。這些法律法規及其解釋和應用也可能不時發生變化，這些變化可能對我們的業務、投資和運營結果產生重大不利影響。此外，不遵守適用的法律法規（根據解釋和適用）可能對我們的業務和運營結果產生重大不利影響。

與我們的股票相關的風險

如果我們未能遵守納斯達克的繼續上市要求，我們可能面臨被除牌的風險，這將導致我們的股票在公開市場上受限，限制我們利用現有流動性設施的能力，並且對我們而言獲得未來融資將更加困難。

在2023年12月1日，公司收到了納斯達克納斯達克上市資格部門發送的首次通知函（“首次通知函”通知公司其股東權益金額已降至1000萬美元以下（“最低股東權益要求”）。公司截至2023年12月31日的股東虧損金額爲（3,963,039）美元。首次通知函還指出，截至2023年9月30日，公司未達到納斯達克全球市場的替代上市標準，包括「市值」標準或「總資產/總收入」標準。首次通知函進一步指出，公司可能考慮申請將公司證券轉至納斯達克資本市場，這將要求公司在其他事項之外，符合納斯達克的持續上市要求。2024年8月14日，納斯達克聽證會小組批准了公司將公司證券從納斯達克全球市場轉至納斯達克資本市場的請求，生效日期爲2024年8月16日開盤交易時。

2024年4月14日，公司收到了一封來自納斯達克的額外通知函，稱公司未符合納斯達克5450(a)(1)上市規則，因公司的A類普通股最低買盤價連續30個工作日低於1.00美元（“最低 買盤價格要求”。不符合規定的通知對公司普通股在納斯達克上市或交易沒有立即影響。公司有180個日曆日，即至2024年10月14日之前，恢復符合最低買盤價格要求。爲了恢復符合，公司普通股的最低買盤價必須在這180個日曆日寬限期內連續10個工作日達到或超過1.00美元每股。若公司在2024年10月14日之前未恢復符合最低買盤價格要求，公司可能有資格獲得額外的180個日曆日符合期，因爲其選擇轉至納斯達克資本市場。要符合條件，公司需要符合公開持股市值和納斯達克資本市場的所有其他最初上市標準，除了買盤價格要求，還需要提供書面通知表明其打算在第二符合期間糾正買盤價不足。公司在此期間未能恢復符合可能導致退市。公司打算積極監控其普通股的買盤價，並在適當情況下考慮實施可用的選項以恢復符合最低買盤價格要求。

開啓 2024 年 5 月 30 日，公司收到了來自納斯達克的另一封通知信（”第三封通知信”) 表示該公司尚未恢復遵守繼續上市的最低股東權益要求 初始通知信中對此進行了討論，根據其合規計劃，它必須在2024年5月29日之前開會。第三次通知 信中通知公司，除非公司要求納斯達克聽證會小組舉行上訴聽證會（”小組”) 到2024年6月6日，公司普通股將在2024年6月10日開業時暫停交易，並附上表格 25-NSE將向美國證券交易委員會提交，美國證券交易委員會將取消該公司的證券在納斯達克的上市和註冊（此類通知， 這個”退市通知”).

根據第三封通知函的指示，公司及時請求在全球貨幣上市公司（The Nasdaq Global Market）的股票從納斯達克全球市場（The Nasdaq Global Market）轉至納斯達克資本市場（The Nasdaq Capital Market）的日期將在2024年8月16日股市開市前生效。委員會還同意公司有至2024年11月26日展示其以前提交的計劃達標成爲可能的期限。公司正在努力解決終止上市通知書中闡明的不足，並計劃儘快恢復符合繼續上市的要求。

儘管公司相信自己能夠符合納斯達克的持續上市要求，但無法保證公司將能夠恢復符合所有適用要求或保持符合任何其他上市要求，尤其是因爲公司的股票已在持續時間內交易低於1.00美元。納斯達克判定我們未能符合納斯達克持續上市標準可能導致我們的證券根據除牌通知被納斯達克除牌。

我們的普通股退市及無法在其他國家證券市場上市可能會對我們產生負面影響：(i)減少我們普通股的流動性和市場價格；(ii)減少願意持有或收購我們普通股的投資者數量，可能對我們籌集股權融資的能力造成負面影響；(iii)限制我們使用某些註冊聲明進行自由買賣證券的能力，從而限制我們進入公開資本市場的能力；和 (iv)損害我們向員工提供股權激勵的能力。投資者普遍認爲我們存在被退市風險的看法也可能對我們證券的市場價格和普通股的交易量產生負面影響。

公司從未向其股本支付現金分紅，而且公司也不預計在可預見的未來支付分紅派息。

公司從未對其股本支付現金分紅，並目前打算保留任何未來收益用於支持其業務的增長，除了其優先股上的強制性分紅支付，受特拉華州法律約束。未來決定是否支付股息將由董事會自行決定，並取決於公司的財務狀況、營運業績、資本需求、一般業務情況以及董事會認爲相關的其他因素。因此，在可預見的未來，公司普通股可能唯一的收益來源將是資本增值。

如果證券或行業分析師不發佈或停止發佈有關公司、其業務或市場的研究或報告， 或者如果他們對普通股的推薦發生不利變化，普通股的價格和成交量可能會下跌。

普通股票的交易市場，將會受到行業或證券分析師可能發表的有關公司、業務、市場或競爭對手的研究和報告的影響。如果任何可能覆蓋公司的分析師們改變對普通股不利的推薦，或者對競爭對手提供更有利的相對推薦，那麼普通股票的價格很可能會下跌。如果覆蓋公司的任何分析師停止覆蓋或者未能定期發佈有關公司的報告，我們可能會在金融市場上失去曝光度，這可能會導致公司證券的股價或成交量下降。

公司的股價可能會波動，您可能無法以購買股票時的價格賣出股票，也可能無法在權證到期時獲得任何價值。

普通股價格的波動可能導致您的全部或部分投資損失。如果我們的證券有一個活躍的市場並持續存在，普通股的交易價格可能會波動，並對各種因素做出不同程度的反應，其中一些因素超出我們的控制。

影響我們普通股交易價格的因素可能包括:

廣泛的市場和行業因素可能會嚴重影響我們證券的市場價格，無論我們的運營表現如何。總體上股票市場和納斯達克已經經歷了價格和成交量的波動，這些波動通常與受影響的特定公司的運營績效無關或不成比例。這些股票和我們證券的交易價格和估值可能難以預測。投資者對零售股票市場或被視爲與公司相似的其他公司股票的信心減退可能導致我們的股價下跌，而與我們的業務、前景、財務狀況或運營結果無關。公司證券的市場價格下跌還可能對其發行額外證券的能力以及未來融資能力造成不利影響。

前瞻性聲明特別說明

本招股說明書補充材料、隨附的招股說明書以及我們在美國證券交易委員會提交的文件，這些文件在本招股說明書補充材料和隨附的招股說明書中被引用，包含了關於未來事件和我們未來業績的前瞻性聲明，這些聲明基於我們當前的期望、估計、預測和展望，以及我們管理層當前的信念和假設，包括關於我們業務、財務狀況、經營成果、運營需求和資本資源利用，以及我們所處的行業和環境。包含諸如「相信」、「可能」、「將」、「估計」、「繼續」、「預期」、「會」、「可能」、「應該」、「打算」和「期望」等詞語的陳述，這些詞語的變體以及類似表達，旨在識別前瞻性聲明。這些前瞻性聲明僅適用於本招股說明書補充材料和隨附的招股說明書的日期，並受難以預測的風險、不確定性和假設影響。因此，實際結果可能與任何前瞻性聲明中表達的結果有實質和負面差異。可能導致或有助於產生這些差異的因素，以及我們認爲影響我們業績的其他因素，包括我們在年度報告10-K和修訂後截至2023年12月31日的年度報告、以及我們在此引用的截至2024年3月31日和2024年6月30日的季度報告10-Q中討論的內容。雖然前瞻性聲明是基於我們管理層在發出時的合理期望，但您不應該依賴它們。我們不承擔任何公開修改或更新任何前瞻性聲明的義務，無論出於何種原因，包括基於新信息、未來事件或其他，除非法律要求。風險因素”和“管理層對財務狀況和經營業績的討論和分析在我們修訂的截至2023年12月31日的年度報告10-K中，以及我們截至2024年3月31日和2024年6月30日的季度報告10-Q中，我們相信會影響我們業績的部分的名稱。我們在此引用，以及我們向美國證券交易委員會提交的其他報告中討論的內容。儘管前瞻性聲明是基於我們管理層在發出時的合理期望，但您不應依賴它們。我們不對任何理由公開修改或更新任何前瞻性說明，除非法律要求這樣做。

使用收益

我們估計，扣除配售代理費和預計發行後，本次發行的淨收益 我們應付的費用約爲1,245,000美元。我們打算使用本次發行的淨收益 用於營運資金和一般公司用途，其中可能包括運營費用、研發費用以及待定和未來支出 收購。此外，我們打算將本次發行的部分淨收益用於贖回任何未償還的A系列優先股 股票和A-1系列優先股，包括此類贖回時應付的任何應計利息和/或對價。每一個 A系列優先股和A-1系列優先股可按其1,000美元的原始發行價以現金兌換，但須進行調整， 加上應計和未付的股息。參見標題爲” 的部分股本的描述” 了解更多信息。

我們實際支出的金額和時間將取決於諸多因素，包括在“ 本招股說明書和這裏和那裏引用的文件中描述的因素，以及用於運營中的現金金額。 我們可能發現需要或建議將淨收益用於其他目的。風險因素在本招股說明書補充中，隨附的招股說明書以及在此和那裏所併入的文件，以及我們在業務運營中使用的現金數額等，都代表着我們基於目前計劃和業務狀況所做的意圖。我們對本次發行的淨收益的預期使用以及我們現有的現金及現金等價物，均取決於我們當前的計劃和業務狀況，這些可能會隨着我們的計劃和業務狀況變化而改變。我們可能會發現有必要或者明智地將淨收益用於其他目的，我們的管理層在將本次淨收益應用於我們之前將有廣泛的自主權，包括用於上述任何目的。在利用本次淨收益前，我們打算將其投資於利息產生、投資級別的證券、存款證書或政府債券。

CAPITALIZATION

下表列出了我們截至2024年6月30日的資本結構：

您應該將這張表格與我們的基本報表和相關附註，以及我們最近的“管理層對財務狀況和業務成果的討論和分析”，一起閱讀，這些已被引用並納入本招股說明書補充資料。

上述表格和討論基於2024年6月30日尚有的14,755,144股普通股，以及該日期調整後的123,889,977股，並排除2024年6月30日之前保留用於發行的普通股或可發行股份的情況：

稀釋

如果您投資於我們的普通股，您的所有權利益將因本次公開發行價格與本次發行後每股經過調整的淨有形資產賬面價值之間的差額而被稀釋。我們通過將有形資產減去總負債得出淨有形資產賬面價值，再除以我們的普通股的流通股份數來計算每股淨有形資產賬面價值。關於每股淨有形資產賬面價值的稀釋代表本次發行中普通股購買者每股支付金額與本次發行後我們的普通股淨有形資產賬面價值之間的差額。截至2024年6月30日，我們的普通股淨有形資產賬面價值爲-416萬8200美元，即每股普通股約爲-0.283美元。

考慮到以下因素:(i)根據調整後的假設進行，自2024年6月30日以來，共發行28217265股普通股，淨收益爲2299345美元，並自2024年6月30日以來，以非現金形式發行65292568股；(ii)在本次發行中以0.096美元的發行價出售15625000股普通股，並扣除我們應付的放置代理費和預計的發行費用（估計爲130,000美元），假設2024年6月30日，我們調整後的淨有形賬面價值將約爲(-964,170)美元，或約爲0.008美元/股。這代表了每股普通股對我們現有股東的淨有形賬面價值的立即增加約0.012美元，並對此次發行的普通股購買者的調整後的淨有形賬面價值產生了約0.088美元/股的立即攤薄，如下表所示：

上表和上述討論基於2024年6月30日時15755144股流通普通股，以及截至該日期調整後的123889977股，且不包括截至2024年6月30日時，保留用於我們全權獎勵計劃下發行或者可能發行的普通股：

在我們尚未行使的任何期權或權證得到行使的情況下，我們可能根據股票激勵計劃授予額外的期權或其他獎勵，或發行額外的權證，或在未來發行額外的普通股，這可能會導致進一步稀釋。

分銷計劃

Maxim Group LLC已同意作爲我們這次發行的獨家承銷代理，但需遵守於2024年10月21日簽署的承銷代理協議的條款和條件。承銷代理並不購買或出售本招股說明書所提供的任何證券，也無需安排購買或銷售任何特定數量或金額的證券，但已同意盡其合理最大努力安排賣出所有在此處提供的證券。我們已直接與投資者簽署了一份證券購買協議，但不一定能全部出售本招股說明書所提供的證券數量。我們將僅向有限數量的合格機構買家和認可投資者提供要約。承銷代理可能在與本次發行有關的情況下保留子代理和挑選的經銷商。

我們已同意對放置代理商承擔特定責任，包括《1933年證券法》（經修訂）下的責任，併爲放置代理商可能需要支付的款項作出貢獻。證券法，併爲放置代理商可能需要支付的款項作出貢獻。

費用和支出

我們已同意向Maxim Group LLC支付現金費用105,000美元，或本次發行中我們賣出的證券購買價格的7.00%。 下表顯示了我們將支付給配售代理的每股和總現金費用，這是與根據本副刊和附帶招股說明書出售的證券相關聯的，假設購買本次招股說明書所展示的所有證券。

我們估計，由我們支付的發行總費用，不包括安置代理費用，將約爲130,000美元，其中包括我們同意在與此發行有關的事務中向Maxim Group LLC報銷的最高25,000美元的法律費用和支出。

放置代理可能被視爲《證券法》第2(a)(11)條的承銷商，並且在其作爲主體出售的證券再銷售時收取的任何佣金和任何獲利可能被視爲《證券法》下的承銷折扣或佣金。作爲承銷商，放置代理將需要遵守《證券法》和《交易法》的要求，包括但不限於《證券法》第415(a)(4)條和《交易法》第100億.5條和m法規。這些規則和法規可能會限制放置代理作爲主體進行證券買賣的時間。根據這些規則和法規，放置代理：

自主帳戶

認購代理不打算向其具有自由裁量權的帳戶確認所提供的證券出售。

上市

我們的普通股票在納斯達克上市，股票代碼爲「JTAI」。

封閉協議

在2024年10月10日，我們的董事和高管們就一項於2024年10月11日結束的發行活動簽署了鎖定協議。根據這些協議，除特定例外情況外，這些個人同意在該發行結束後的90天內，不得出售或轉讓任何普通股或可轉換成我公司普通股的證券，或者可兌換成我公司普通股的或者可行權的證券。具體而言，這些個人同意，在一定程度上，不得提供、抵押、賣出、簽訂賣出協議、出售任何購買期權或賣出合約、購買任何購買期權或賣出合約、授予任何購買期權、權利或售賣認股權證的權利，或者以其他方式處置轉讓他們持有的任何普通股或可轉換成我方普通股的證券或可兌換成或可行權爲我方普通股的證券。

儘管存在這些限制，這些普通股可以在有限的情況下進行轉讓，包括但不限於作爲禮物、遺囑或遺產繼承。

此外，我們同意不發行、簽訂任何發行協議，或公佈普通股或普通股等價物的發行或擬議發行，亦不會提交任何註冊聲明，除了2024年9月3日向美國證券交易委員會初始提交的生效註冊聲明表S-1(文件號333-281911) （“蘋果公司CEO庫克大規模拋售股票，套現逾3億港元，資金已存入上市公司設立的專項帳戶(「信託帳戶」)，以公共股東(定義詳見下文)爲受益人的註冊聲明(FORM S-1)中所規定的一定金額及特定款項。信託帳戶中持有的基金類型(包括資金持有的利息)除支付公司稅費以外，一旦實現以下最早的情況之一即可支取: (i) 完成首次（業務）組合；(ii) 如果公司未能在2025年3月3日之前完成首次（業務）組合，則可以贖回100%的發行股份（如下所述）；或 (iii) 股東表決贖回發行股份。 若要批准修訂本Amended and Restated Certificate，必須就修訂對決定最早如下情形之一的公司的義務以在首次業務組合中允許贖回或未在終止日期之前完成首次業務組合即贖回100%的發行股份產生影響或涉及股東權益或首次業務組合前的活動（如第9.7節所述），對修訂進行表決。發售期(「發售期」)所出售單位的組成部分的Common Stock股份的持有人(「發售股份」)，不論這些發售股份是在發售期內還是在發售市場上的二級市場中購買，也不論這些持有人是公司的發起人，高管或董事，或上述任何關聯方的子公司，均在此被稱爲「公共股東」。），註冊聲明中包含的任何初步招股說明書，最初提交或作爲任何修訂的一部分提交的文件，或根據SEC證券法規424（a）規定提交給SEC的文件，根據註冊聲明提交的最終定價招股說明書，或者以員工福利計劃爲由提交S-8表的註冊聲明。

其他關係

配售代理及其某些關聯公司是全方位的金融機構，從事各種活動，包括證券交易、商業和投資銀行業務、金融諮詢、投資管理、投資研究、主要投資、對沖、融資和經紀業務。配售代理及其某些關聯公司曾經或將來執行各種商業和投資銀行業務和金融諮詢服務，因此收取或將收取定製的費用和費用。

在各自業務活動的普通過程中，放置代理人及其某些關聯方可能進行或持有各種廣泛的投資，並積極交易債務和股權證券（或相關衍生證券）和金融工具（包括銀行貸款），爲自己的帳戶和客戶的帳戶，這種投資和證券活動可能涉及我們及我們關聯方發行的證券和/或工具。 放置代理人及其某些關聯方還可能就這些證券或工具發表獨立的投資建議、市場信息或交易想法和/或發佈或表達獨立的研究觀點，並可能隨時持有或建議客戶取得該等證券或工具的做多和/或做空頭寸。

股本的簡介。

授權資本

公司有權發行20,400萬股股票，分爲兩類：普通股2億股和優先股400萬股，其中1,127股被指定爲A系列優先股，575股被指定爲A-1系列優先股，另外5,000股被指定爲B系列優先股。截至2024年10月17日，公司擁有以下未流通證券：

普通股

表決權

公司的公司章程規定，除非公司章程另有明文規定或法律另有規定，普通股股東應始終以單一類別一致表決所有事項；但是，除非法律另有要求，普通股股東不得對任何僅涉及一項或多項優先股系列條款的公司章程修正案進行投票，如果此類受影響系列的持有人依據公司章程有權分開或與其他一項或多項此類系列的持有人作爲一類一起投票，則有關係列。除非公司章程另有明文規定或適用法律要求，每位普通股股東應有權按其名下持有的每股普通股進行一票表決。

股息權

根據可能適用於當時尚未變動的優先股的任何偏好，普通股將在每股基礎上平等、一致地和按比例地受到公司董事會根據公司合法可用資產不時宣佈和支付的任何股息或按比例分紅。

權利 在清算、解散和清算中

在公司清算、解散或清盤時（無論是自願或非自願），除了任何持續優先股的權利外，普通股股東將享有按比例分享公司可供分配給股東的所有資產。

Other Rights

The holders of common stock do not have preemptive, subscription, redemption or conversion rights. There will be no redemption or sinking fund provisions applicable to the common stock. The rights, preferences and privileges of holders of shares of common stock will be subject to those of the holders of any shares of preferred stock that the Company may issue in the future.

Preferred Stock

Series A Convertible Preferred Stock

On August 10, 2023, the Company filed the Certificate of Designation of the Series A Convertible Preferred Stock (the “Series A Certificate”) with the Secretary of State of the State of Delaware, establishing the rights, preferences, privileges and other terms relating to the Series A Preferred Shares. The Series A Preferred Shares rank senior to the common stock with respect to distribution rights and rights upon liquidation. Subject to certain exceptions, so long as any of the Series A Preferred Shares remain outstanding, unless all dividends for all preceding full fiscal quarters have been declared and all accumulated dividends have been paid with respect to the Company’s preferred stock, no dividend or distribution will be declared or paid on, and no redemption or repurchase will be agreed to or consummated of, stock on a parity with the Series A Preferred Shares, common stock, or any other shares of stock junior to the Series A Preferred Shares.

Each of the Series A Preferred Shares has a stated value of the Series A Original Purchase Price (as defined in the Series A Certificate), and holders of the Series A Preferred Shares will be entitled to cumulative dividends at the annual rate of 8% of the liquidation preference, payable quarterly commencing on September 1, 2023. Dividends may be paid in cash or, in whole or in part, in PIK Shares (as defined in the Series A Certificate). If dividends are paid in PIK Shares, the PIK Shares will be valued at the closing price of such securities on the trading day prior to the date the dividend is declared by the Company’s Board of Directors. The Company’s Board of Directors has authorized the Company, to the extent the payment of dividends is permitted under Delaware law, for the foreseeable future, to pay dividends in PIK Shares.

Holders of the Series A Preferred Shares have the right to vote on matters submitted to a vote of the holders of Common Stock on an as-converted basis unless required by applicable law. Holders of the Series A Preferred Shares will be entitled to a number of votes equal to the number of votes such holder would have had if all Series A Preferred Shares held by such holder had been converted into shares of common stock. So long as any of the Series A Preferred Shares are outstanding, the affirmative vote or consent of the holders of the Series A Preferred Shares constituting at least 90% of the outstanding Series A Preferred Shares, voting together as a separate class, will be necessary to: (i) amend, alter or repeal any provision of the Certificate of Incorporation or the Series A Certificate if such amendment, alteration or repeal would alter or change the powers, preferences or special rights of the Series A Preferred Shares so as to affect them adversely; (ii) create, or authorize the creation of, or issue any series of Series A Dividend Senior Stock, or reclassify any class or series of capital stock into any series of Series A Dividend Senior Stock (as defined in the Series A Certificate); (iii) purchase or redeem, or permit any subsidiary of the Company to purchase or redeem, any shares of any Series A Dividend Junior Stock, Series A Liquidation Junior Stock, Series A Qualifying Merger Junior Stock or Series A Qualifying Sale Junior Stock (each as defined in the Series A Certificate), other than repurchases of shares of such capital stock from former directors, officers, employees, consultants or other persons performing services for the Company or any subsidiary of the Company in connection with the cessation of employment or service and for a purchase price per share of such capital stock not exceeding the original purchase price thereof; (iv) incur, or permit the Company’s subsidiaries to incur, or issue, or permit the Company’s subsidiaries to issue, any indebtedness for borrowed money (except payables and obligations incurred in the ordinary course of the Company’s business), including obligations (whether or not contingent), under guaranties, or loans or debt securities, including equity-linked or convertible debt securities that, in total, results in gross proceeds to the Company of $20.0 million or greater; (v) declare or pay any cash dividend on any Series A Dividend Junior Stock; or (vi) enter into, or permit the Company’s subsidiaries to enter into, any agreement, arrangement or understanding providing for any of the foregoing actions.

Holders of the Series A Preferred Shares may convert their Series A Preferred Shares at any time into a number of shares of common stock equal to the Series A Conversion Price (as defined in the Series A Certificate); provided, however, in no event shall outstanding Series A Preferred Shares be converted into more than 19.99% of the outstanding shares of common stock.

The Company may, subject to certain conditions, cause the outstanding Series A Preferred Shares to be redeemed in cash at the “Series A Redemption Price” which is the Series A Original Purchase Price, subject to certain adjustments, plus the aggregate amount of dividends then accrued and unpaid on such Series A Preferred Shares. The Company was required to redeem all the Series A Preferred Shares that remain outstanding as of the one-year anniversary of the original issue date; however, the outside date for redemption was automatically extended by an additional three (3) month period because the Company has not closed upon one or more equity financings that, in total, result in gross proceeds to the Company of $10 million or greater. If the Company raises equity capital, 15% of the proceeds net of expenses must be used to pay the redemption price on the Series A Preferred Shares.

In July 2024 the Company and Maxim entered into an amendment a settlement agreement relating to the Company’s initial public offering whereby the Company and Maxim agreed to, among other things, amend the definition of the “Series A Conversion Price” for the Series A Preferred Shares and certain restrictions with respect to shares of the Company’s common stock Maxim may acquire upon the conversion of its Series A Preferred Shares.

Series A-1 Convertible Preferred Stock

On August 10, 2023, the Company filed the Certificate of Designation of the Series A-1 Convertible Preferred Stock (the “Series A-1 Certificate”) with the Secretary of State of the State of Delaware, establishing the rights, preferences, privileges and other terms relating to the Series A-1 Preferred Shares. The Series A-1 Preferred Shares ranks senior to the common stock with respect to distribution rights and rights upon liquidation but junior to the Series A Preferred Shares. Subject to certain exceptions, so long as any Series A-1 Preferred Shares remain outstanding, unless all dividends for all preceding full fiscal quarters have been declared and all accumulated dividends have been paid with respect to the Company’s preferred stock, no dividend or distribution will be declared or paid on, and no redemption or repurchase will be agreed to or consummated of, stock on a parity with the Series A-1 Preferred Shares, common stock or any other shares of stock junior to the Series A-1 Preferred Shares.

Each of the Series A-1 Preferred Shares has a stated value equal to the Series A-1 Original Purchase Price (as defined in the Series A-1 Certificate), and commencing on the six month anniversary of the original issuance date the Series A-1 Preferred Shares, holders of the Series A-1 Preferred Shares will be entitled to cumulative dividends at the annual rate of 5% of the liquidation preference, payable quarterly commencing on and including April 1, 2024 (but, with respect to any Series A-1 Preferred Shares outstanding on or after the six month anniversary date of their original issuance date, dividends will be deemed to have accrued as of August 10, 2023).

Holders of the Series A-1 Preferred Shares have the right to vote on matters submitted to a vote of the holders of Common Stock on an as-converted basis unless required by applicable law. Holders of the Series A-1 Preferred Shares will be entitled to a number of votes equal to the number of votes such holder would have had if all of the Series A-1 Preferred Shares held by such holder had been converted into shares of common stock. So long as any of the Series A-1 Preferred Shares are outstanding, the affirmative vote or consent of the holders of the Series A-1 Shares of at least 90% of the outstanding Series A-1 Preferred Shares, voting together as a separate class, will be necessary to: (i) amend, alter or repeal any provision of the Certificate of Incorporation or the Series A-1 Certificate if such amendment, alteration or repeal would alter or change the powers, preferences or special rights of the Series A-1 Preferred Shares so as to affect them adversely; (ii) create, or authorize the creation of, or issue any series of Series A-1 Dividend Senior Stock Price (as defined in the Series A-1 Certificate), or reclassify any class or series of capital stock into any series of Series A-1 Dividend Senior Stock; (iii) purchase or redeem, or permit any subsidiary of the Company to purchase or redeem, any shares of any Series A-1 Dividend Junior Stock, Series A-1 Liquidation Junior Stock, Series A-1 Qualifying Merger Junior Stock or Series A-1 Qualifying Sale Junior Stock Price (each as defined in the Series A-1 Certificate), other than repurchases of shares of such capital stock from former directors, officers, employees, consultants or other persons performing services for the Company or any subsidiary of the Company in connection with the cessation of employment or service and for a purchase price per share of such capital stock not exceeding the original purchase price thereof; (iv) incur, or permit the Company’s subsidiaries to incur, or issue, or permit the Company’s subsidiaries to issue, any indebtedness for borrowed money (except payables and obligations incurred in the ordinary course of the Company’s business), including obligations (whether or not contingent), under guaranties, or loans or debt securities, including equity-linked or convertible debt securities that, in total, results in gross proceeds to the Company of $20 million or greater; (v) declare or pay any cash dividend on any Series A-1 Dividend Junior Stock; or (vi) enter into, or permit the Company’s subsidiaries to enter into, any agreement, arrangement or understanding providing for any of the foregoing actions.

Holders of the Series A-1 Preferred Shares may convert their Series A-1 Preferred Shares at any time into a number of shares of common stock equal to the quotient of the Series A-1 Original Purchase Price divided by the Series A-1 Conversion Price (as defined in the Series A-1 Certificate); provided, however, in no event shall outstanding Series A-1 Preferred Shares be converted into more than 19.99% of the outstanding shares of common stock.

The Company may, subject to certain conditions, cause the outstanding Series A-1 Preferred Shares to be redeemed in cash at the “Series A-1 Redemption Price” which is the Series A-1 Original Purchase Price, subject to certain adjustments, plus the aggregate amount of dividends then accrued and unpaid on such Series A-1 Preferred Shares. The Company was required to redeem all of the Series A-1 Preferred Shares that remain outstanding as of the one-year anniversary of the original issue date; however, the outside date for redemption was automatically extended by an additional three (3) month period because the Company has not closed upon one or more equity financings that, in total, result in gross proceeds to the Company of $10 million or greater. If the Company raises equity capital, 15% of the proceeds net of expenses must be used to pay the redemption price on the Series A Preferred Shares and an additional 15% of the proceeds net of expenses must be used to pay the redemption price on the Series A-1 Preferred Shares.

Series B Preferred Stock

On March 28, 2024, the Company filed the Certificate of Designations of the Series B Preferred Shares (the “Series B Certificate”) with the Secretary of State of the State of Delaware, establishing the rights, preferences, privileges and other terms relating to the Series B Preferred Shares. The Series B Preferred Shares rank pari passu with the Series A Preferred Shares and Series A-1 Preferred Shares and senior to all other capital stock of the Company.

Each of the Series B Preferred Shares converts into a number of shares of our common stock, subject to certain limitations, including a beneficial ownership limitation of 4.99% (calculated in accordance with the rules promulgated under Section 13(d) of the Exchange Act), which can be adjusted to a beneficial ownership limitation of 9.99% upon 61 days prior written notice by Ionic. Prior to such conversion approval, we may not convert the Series B Preferred Shares into shares of common stock if, as a result of such conversion, the number of shares of common stock to be issued exceeds 19.9% of the total number of shares of common stock outstanding.

Subject to the limitations set forth in the preceding paragraph and provided there is an effective registration statement covering Ionic’s resale of common stock underlying the Series B Preferred Shares, the Series B Preferred Shares will automatically convert into shares of common stock on or prior to the tenth trading day after the issuance date of such Series B Preferred Shares. The number of shares of common stock issuable upon conversion of each of the Series B Preferred Shares is calculated by dividing the conversion amount per share of Series B Preferred Shares by the then conversion price. The conversion amount is equal to the stated value of the Series B Preferred Shares, which is $10,000, plus any additional amounts and late charges calculated in accordance with the Series B Certificate. The conversion price is equal to 90% (or, in the case of a delisting, 80%) of the lowest daily VWAP of our common stock over a period beginning on the trading day after we deliver shares of common stock upon such conversion to Ionic and ending on the trading day on which the aggregate dollar trading volume of our common stock exceeds seven times the applicable conversion amount, subject to a five trading day minimum period for such calculation, and subject to certain adjustments.

If certain defined “triggering events” defined in the Series B Certificate occur, such as a breach of the Ionic Registration Rights Agreement (as defined in the Series B Certificate), suspension of trading, or our failure to convert the Series B Preferred Shares into common stock when a conversion right is exercised, then we may be required to redeem the Series B Preferred Shares for cash at 110% of the stated value.

Warrants

Ionic Warrant

The Ionic Warrant entitles Ionic to purchase up to 1,500 Series B Preferred Shares, provided any such exercise shall be for a minimum of fifty (50) Series B Preferred Shares. The Ionic Warrant exercise price is initially set at $10,000 per share of the Series B Preferred Shares, subject to adjustment for certain events, such as stock split, issuance of additional shares as a dividend or otherwise. The Ionic Warrant has a term of two years. At any time when the Ionic Warrant is exercisable for less than 1,000 of the Series B Preferred Shares, the Company shall have the right to redeem all or a portion of the Ionic Warrant by paying to the holder an amount in cash equal to $100 per share of Series B Preferred Shares that would otherwise be issuable pursuant to the Ionic Warrant.

GEM Warrant

The GEM Warrant entitles GEM to purchase up to 6% of the outstanding common stock of the Company on a fully diluted basis as of the date of listing. The GEM Warrant has a term of three years. The exercise price of the GEM Warrant, as of June 30, 2024, was $5.81 per share; provided, that, if the average closing price of the Company’s common stock for the 10 trading days following the first anniversary of the date of listing is less than 90% of the then current exercise price of the GEM Warrant (the “Reset Event”), then the exercise price of the GEM Warrant will be adjusted to 110% of our then current trading price. Given that the Reset Event occurred, the revised exercise price of the GEM Warrant is $0.24. The warrant may be exercised by payment of the per share amount in cash or through a cashless exercise.

The GEM Warrant provides that GEM can elect to limit the exercisability of the GEM Warrant such that it is not exercisable to the extent that, after giving effect to the exercise, GEM and its affiliates, to the Company’s actual knowledge, would beneficially own in excess of 4.99% of the Company’s common stock outstanding immediately after giving effect to such exercise. GEM has made this election, which makes funds available in excess of this 4.99% ownership limit up to a 9.99% ownership restriction. GEM may revoke this election by providing written notice, which revocation will not be effective until the sixty-first (61st) day thereafter.

LEGAL MATTERS

The validity of the issuance of the securities offered hereby will be passed upon by our counsel, Dykema Gossett PLLC. The placement agent is being represented in connection with this offering by Pryor Cashman LLP.

EXPERTS

The consolidated financial statements of the Company as of December 31, 2023 and December 31, 2022 included in this prospectus supplement have been audited by Hacker Johnson & Smith P.A., an independent registered public accounting firm, as set forth in their report thereon appearing elsewhere herein, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, and are included in reliance upon such report given on the authority of such firm as experts in accounting and auditing.

WHERE YOU CAN FIND MORE INFORMATION

We file reports, proxy statements and other information with the SEC. This prospectus supplement and the accompanying prospectus, which constitute a part of the registration statement, does not contain all the information that is in the registration statement and its exhibits and schedules. Statements in this prospectus that summarize documents are not necessarily complete, and in each case you should refer to the copy of the document filed as an exhibit to the registration statement. The registration statement and other public filings can be obtained from the SEC’s website at www.sec.gov.

As a public company, we are required to file our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, proxy statements on Schedule 14A and other information (including any amendments) with the SEC. You can find the Company’s SEC filings at the SEC’s website at www.sec.gov.

Our Internet address is www.jet.ai. Information contained on our website is not part of this prospectus. Our SEC filings (including any amendments) will be made available free of charge on www.sec.gov, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC.

INCORPORATION BY REFERENCE

The SEC allows us to incorporate by reference the information and reports we file with it, which means that we can disclose important information to you by referring you to these documents. Our SEC file number is 001-40725. The information incorporated by reference is an important part of this prospectus, and information that we file later with the SEC will automatically update and supersede the information already incorporated by reference. We are incorporating by reference the documents listed below, which we have already filed with the SEC, and any future filings we make with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, except as to any portion of any future report or document that is not deemed filed under such provisions, until we sell all of the securities:

Upon written or oral request, we will provide, without charge, to each person, including any beneficial owner, to whom a copy of this prospectus is delivered a copy of the documents incorporated by reference into this prospectus. You may request a copy of these filings, and any exhibits we have specifically incorporated by reference as an exhibit in this prospectus, at no cost by writing or telephoning us at the following address:

Jet.AI Inc.

Attn: Corporate Secretary

10845 Griffith Peak Drive

Suite 200

Las Vegas, NV 89135

(702) 747-4000

This prospectus is part of a registration statement we filed with the SEC. We have incorporated exhibits into this registration statement. You should read the exhibits carefully for provisions that may be important to you.

You should rely only on the information incorporated by reference or provided in this prospectus or any prospectus supplement. We have not authorized anyone to provide you with different information. We are not making an offer of these securities in any state where the offer is not permitted. You should not assume that the information in this prospectus or in the documents incorporated by reference is accurate as of any date other than the date on the front of this prospectus or those documents.

Prospectus

$50,000,000

Common Stock

Preferred Stock

Debt Securities

Warrants

Rights

Units

This prospectus provides you with a general description of the securities that Jet.AI Inc. may offer and sell, from time to time, either individually or in units. Each time we sell securities pursuant to this prospectus we will provide a prospectus supplement that will contain specific information about the terms of any securities we offer and the specific manner in which we will offer such securities. The prospectus supplement will also contain information, where appropriate, about material United States federal income tax consequences relating to, and any listing on a securities exchange of, the securities covered by the prospectus supplement. The prospectus supplement may also add, update or change information contained in this prospectus. You should read this prospectus and the applicable prospectus supplement carefully before you invest in our securities.

We may offer these securities in amounts, at prices and on terms determined at the time of offering. We may sell the securities directly to you, through agents we select, or through underwriters and dealers we select. If we use agents, underwriters or dealers to sell the securities, we will name them and describe their compensation in a prospectus supplement.

Our common stock is listed on the Nasdaq Capital Market under the symbol “JTAI.” On August 22, 2024, the closing price for our common stock as reported on the Nasdaq Capital Market was $0.20 per share. Our principal executive offices are located at 10845 Griffith Peak Dr., Suite 200, Las Vegas, Nevada 89135.

As of August 22, 2024, the aggregate market value of our outstanding shares of common stock held by non-affiliates was approximately $1,192,315 based on 24,576,880 shares of common stock outstanding, of which 17,884,715 shares were held by non-affiliates on such date, and based on a closing sale price of our common stock of $0.20 per share on that date. Pursuant to General Instruction I.B.6 of Form S-3, in no event will we sell securities in a public primary offering with a value exceeding one-third of our public float in any 12-month period so long as our public float remains below $75,000,000.

Investing in our securities involves a high degree of risk. You should review carefully the risks and uncertainties described under the heading “Risk Factors” contained in this prospectus beginning on page 3 and the applicable prospectus supplement, and under similar headings in the other documents that are incorporated by reference into this prospectus.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

The date of this prospectus is September 9, 2024.

Table of Contents

ABOUT THIS PROSPECTUS

This prospectus is part of a registration statement filed with the Securities and Exchange Commission (the “SEC”), utilizing a shelf registration process. Under this shelf registration process, we may sell any combination of the securities described in this prospectus, either individually or in units, in one or more offerings, up to a total dollar amount of $50,000,000.

This prospectus provides you with a general description of the securities we may offer. Each time we sell securities, we will provide a prospectus supplement that will contain specific information about the terms of that specific offering. The prospectus supplement may also add, update or change information contained in this prospectus. You should read this prospectus and the applicable prospectus supplement together with the additional information described under the headings “Where You Can Find More Information” and “INFORMATION INCORPORATED BY REFERENCE” and any additional information you may need to make your investment decision.

We have not authorized anyone to provide you with any information or to make any representations other than those contained in this prospectus, any applicable prospectus supplement or any free writing prospectuses prepared by or on behalf of us or to which we have referred you. We take no responsibility for and can provide no assurance as to the reliability of, any other information that others may give you. We will not make an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this prospectus and any applicable prospectus supplement to this prospectus is accurate as of the date on the respective covers of such documents, and that any information incorporated by reference is accurate only as of the date of the document incorporated by reference, regardless of the time of delivery of this prospectus, such prospectus supplement, or any sale or issuance of a security, unless we indicate otherwise. Our business, financial condition, results of operations and prospects may have changed materially since those dates. You should rely only on the information contained or incorporated by reference in this prospectus or any accompanying prospectus supplement.

Unless the context otherwise requires, all references to “Jet.AI,” “the Company,” “we,” “our,” “us” or “our company” in this prospectus refer to Jet AI, Inc., a Delaware corporation, and its subsidiaries together.

ABOUT JET.AI INC.

Jet.AI Inc. was formed on June 4, 2018 in the State of Delaware and is now headquartered in Las Vegas, Nevada. On August 10, 2023, we consummated a business combination pursuant to which Jet Token Inc. (“Jet Token”) combined with Oxbridge Acquisition Corp. (“Oxbridge”), a special purpose acquisition company and in connection with that transaction the combined company was renamed Jet.AI Inc.

We are a private air charter company that develops innovative artificial intelligence (“AI”) technology to facilitate access to travel by private aircraft travel through our iOS and Android charter booking app, CharterGPT (“CharterGPT”), and our B2B software platform (the “Jet.AI Operator Platform”), which provides a suite of software-as-a-service (“SaaS”) products that we offer aircraft owners and operators. We strive to streamline and enhance the aviation experience for both operators and customers by leveraging advanced natural language processing and advanced fleet logistics optimizations.

Our business strategy combines concepts from fractional jet ownership programs and aviation jet membership cards with AI innovations. Our CharterGPT app uses natural language processing and machine learning to improve the private jet booking experience, which is advanced by CharterGPT’s direct connection via our application programming interface (“API”) to Avinode, one of the largest centralized databases for charter services in the private-aviation industry. CharterGPT receives users’ requests for private-aircraft travel, connects users to private-charter operators who have posted their aircraft for hire, displays a variety of charter booking options at a range of prices drawn from thousands of aircraft listings on the Avinode platform along with pricing for our own fleet of four aircraft, and facilitates communication, contract exchange, and payment between the user and the operator of the aircraft ultimately selected for travel.

Our Jet.AI Operation Platform currently consists of the following SaaS products:

We currently have a fleet of five aircraft, including three HondaJet HA-420 aircraft (the “HondaJet Elites”), one Citation CJ4 Gen 2 and one King Air 350i. The three HondaJet Elites are managed, operated, and maintained by Cirrus pursuant to an Executive Aircraft Management and Charter Services Agreement in compliance with all applicable FAA regulations and certification requirements. The Citation CJ4 Gen 2 and King Air 350i in our fleet are owned by customers and managed through our OnBoard Program, which allows aircraft owners to contribute their aircraft to our charter and jet-card inventory after they have completed certain FAA certifications and requirements.

We offer the following programs for our HondaJet Elite aircraft:

In addition to servicing members, fractional owners, and third-party charter clients, our HondaJet Elites are available to address unexpected cancellations or delays on brokered charters. Our ability to maintain a fleet of readily available aircraft to backfill third-party charter services gives us a competitive edge by providing more reliability than our competitors and is an attractive selling point for potential clients.

Corporate Information

Our website address is www.jet.ai. The information contained in, or that can be accessed through, our website is not incorporated by reference into this prospectus and is not part of this prospectus.

Our common stock is listed on the Nasdaq Capital Market under the symbol “JTAI”. Our principal executive office is located at 10845 Griffith Peak Dr., Suite 200, Las Vegas, Nevada 89135, and our telephone number is (702) 747-4000.

RISK FACTORS

Investing in our securities involves a high degree of risk. Please see the risk factors under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023, on file with the SEC, and those risk factors identified in reports subsequently filed with the SEC, including our Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, which are incorporated by reference into this prospectus. Before you invest in our securities, you should carefully consider these risks as well as other information we include or incorporate by reference into this prospectus and the applicable prospectus supplement. The risks and uncertainties we have described are not the only ones facing our company. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our business operations. The occurrence of any of these risks might cause you to lose all or part of your investment in the offered securities. The discussion of risks includes or refers to forward-looking statements; you should read the explanation of the qualifications and limitations on such forward-looking statements discussed elsewhere in this prospectus.

FORWARD-LOOKING STATEMENTS

This prospectus contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties, as well as assumptions that, if they never materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including any projections of financing needs, revenue, expenses, earnings or losses from operations, or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements concerning our products and services and timelines; any statements of expectation or belief; and any statements of assumptions underlying any of the foregoing. In addition, forward looking statements may contain the words “believe,” “anticipate,” “expect,” “estimate,” “intend,” “plan,” “project,” “will be,” “will continue,” “will result,” “seek,” “could,” “may,” “might,” and similar expressions that convey uncertainty of future events or outcomes, or the negative version of those words or phrases or other comparable words or phrases of a future or forward-looking nature.

The forward-looking statements included in this prospectus represent our estimates as of the date of this prospectus. We specifically disclaim any obligation to update these forward-looking statements in the future, except as required by law. These forward-looking statements should not be relied upon as representing our estimates or views as of any date subsequent to the date of this prospectus.

USE OF PROCEEDS

Except as described in any prospectus supplement and any free writing prospectus in connection with a specific offering, we currently intend to use the net proceeds from the sale of the securities offered under this prospectus for general corporate purposes, including the development and commercialization of our SaaS products, aircraft acquisition, research and development, general and administrative expenses, license or technology acquisitions, and working capital and capital expenditures. We may also use the net proceeds to repay any debts and/or invest in or acquire complementary businesses, products, or technologies, although we have no current commitments or agreements with respect to any such investments or acquisitions as of the date of this prospectus. We have not determined the amount of net proceeds to be used specifically for the foregoing purposes. As a result, our management will have broad discretion in the allocation of the net proceeds and investors will be relying on the judgment of our management regarding the application of the proceeds of any sale of the securities. Pending use of the net proceeds, we intend to invest the proceeds in short-term, investment-grade, interest-bearing instruments.

Each time we offer securities under this prospectus, we will describe the intended use of the net proceeds from that offering in the applicable prospectus supplement. The actual amount of net proceeds we spend on a particular use will depend on many factors, including, our future capital expenditures, the amount of cash required by our operations, and our future revenue growth, if any. Therefore, we will retain broad discretion in the use of the net proceeds.

DESCRIPTION OF THE SECURITIES

We may offer, from time to time, in one or more offerings, up to $50,000,000 of the following securities:

The aggregate initial offering price of the offered securities that we may issue will not exceed $50,000,000. Until such time as the aggregate market value of the voting and non-voting common equity held by non-affiliates of the Company is $75.0 million or more, the aggregate market value of securities sold by or on behalf of the Company pursuant to this registration statement during the period of 12 calendar months immediately prior to, and including, a sale under this registration statement will be no more than one-third of the aggregate market value of the voting and non-voting common equity held by non-affiliates of the Company. If we issue debt securities at a discount from their principal amount, then, for purposes of calculating the aggregate initial offering price of the offered securities issued under this prospectus, we will include only the initial offering price of the debt securities and not the principal amount of the debt securities.

This prospectus contains a summary of the general terms of the various securities that we may offer. The prospectus supplement relating to any particular securities offered will describe the specific terms of the securities, which may be in addition to or different from the general terms summarized in this prospectus. Because the summary in this prospectus and in any prospectus supplement does not contain all of the information that you may find useful, you should read the documents relating to the securities that are described in this prospectus or in any applicable prospectus supplement. Please read “Where You Can Find More Information” to find out how you can obtain a copy of those documents.

The applicable prospectus supplement will also contain the terms of a given offering, the initial offering price and our net proceeds. Where applicable, a prospectus supplement will also describe any material United States federal income tax consequences relating to the securities offered and indicate whether the securities offered are or will be quoted or listed on any quotation system or securities exchange.

DESCRIPTION OF COMMON STOCK

This section describes the general terms and provisions of our common stock. The prospectus supplement relating to any offering of common stock, or other securities convertible into or exchangeable or exercisable for common stock, will describe more specific terms of the offering of common stock or other securities, including the number of shares offered, the initial offering price and market price and dividend information. The prospectus supplement may provide information that is different from this prospectus. If the information in the prospectus supplement with respect to our common stock being offered differs from this prospectus, you should rely on the information in the prospectus supplement.

The summary set forth below does not purport to be complete and is subject to and qualified in its entirety by reference to our certificate of incorporation, dated August 10, 2023 (our “Certificate of Incorporation”), and our bylaws, dated August 10, 2023, as amended by the Amendment to the Bylaws, dated August 5, 2023 (as amended, our “Bylaws”), each of which is incorporated by reference as an exhibit to the registration statement of which this prospectus forms a part. We encourage you to read our Certificate of Incorporation and our Bylaws for additional information before you purchase any shares of our common stock. Our common stock and the rights of the holders of our common stock are subject to the applicable statutes of the State of Delaware, our Certificate of Incorporation, and our Bylaws, as amended.

General Terms

We are authorized to issue 55,000,000 shares of common stock. On August 22, 2024, we had 24,576,880 shares of common stock issued and outstanding, held by approximately 32,276 holders of record. Except as otherwise provided by any series of preferred stock that may later be created, holders of our common stock have exclusive voting rights for the election of directors and for all other purposes. Holders of our common stock are entitled to one vote per share on all matters to be voted upon by our stockholders. Neither our Certificate of Incorporation nor our Bylaws authorize cumulative voting. The holders of our common stock are entitled to receive dividends, if any, as may be declared from time to time by our board of directors (our “Board”) out of funds legally available for the payment of dividends, subject to the rights of any series of preferred stock. In the event of a liquidation, dissolution or winding up of Jet.AI, the holders of our common stock are entitled to share ratably in all assets remaining after payment of the preferential amounts, if any, to which the holders of our preferred stock, if any, are entitled. Our common stock has no preemptive, conversion or other subscription rights. There are no redemption or sinking-fund provisions applicable to our common stock. All of our outstanding shares of common stock are fully paid and non-assessable.

Our Board of Directors

Our Bylaws provide that the number of directors constituting our Board is fixed from time to time in accordance with our Certificate of Incorporation, which provides that, subject to the rights of the holders of any series of preferred stock to elect additional directors under specified circumstances, the total number of directors constituting the Board shall be fixed from time to time exclusively by resolution adopted by a majority of the directors then in office, although less than a quorum (as defined in our Bylaws), or by the sole remaining director.

Our Certificate of Incorporation provides for our Board to be divided into three classes of directors serving staggered terms. Approximately one-third of the Board will be elected each year. The provision for a classified Board could prevent a party who acquires control of a majority of our outstanding shares of voting stock from obtaining control of our Board until the second annual stockholders’ meeting following the date the acquirer obtains the controlling stock interest. The classified Board provision could discourage a potential acquirer from making a tender offer or otherwise attempting to obtain control of us and could increase the likelihood that incumbent directors will retain their positions. Our Certificate of Incorporation provides that directors may only be removed for cause by the affirmative vote of the holders of at least two-thirds of the voting power of the then-outstanding shares of our capital stock.

Our Certificate of Incorporation provides that, upon any vacancy occurring in the Board for any cause, and any newly created directorship resulting from any increase in the authorized number of directors, shall, unless (a) the Board determines by resolution that any such vacancies or newly created directorships shall be filled by the stockholders, or (b) as otherwise provided by law, be filled only by the affirmative vote of a majority of the directors then in office, even if less than a quorum, or by a sole remaining director, and not by the stockholders.

Transfer Agent and Registrar

The transfer agent and registrar for our common stock is Continental Stock Transfer & Trust Company.

Nasdaq

Our common stock is listed for quotation on the Nasdaq Capital Market under the symbol “JTAI.”

DESCRIPTION OF PREFERRED STOCK

We are authorized to issue 4,000,000 shares of preferred stock. As of the date of this prospectus, we have designated three classes of preferred stock, being Series A Preferred Stock, Series A-1 Preferred Stock and Series B Preferred Stock. We do not intend to offer and sell any of those series of preferred stock pursuant to this prospectus.

The following description of our preferred stock, together with any additional information we include in any applicable prospectus supplement or any related free writing prospectus, summarizes the material terms and provisions of our preferred stock that we may offer under this prospectus. While the terms we have summarized below will apply generally to any preferred stock that we may offer, we will describe the particular terms of any class or series of these securities in more detail in the applicable prospectus supplement. For the complete terms of our preferred stock, please refer to our Certificate of Incorporation, our Bylaws, and our Certificates of Designation that are incorporated by reference into the registration statement of which this prospectus is a part or may be incorporated by reference in this prospectus or any applicable prospectus supplement. The summary set forth below does not purport to be complete and is subject to and qualified in its entirety by reference to our Certificate of Incorporation, our Bylaws, as amended, and our Certificates of Designation, each of which is incorporated by reference as an exhibit to the registration statement of which this prospectus forms a part. We encourage you to read our Certificate of Incorporation, our Bylaws, as amended, and our Certificates of Designation for additional information before you purchase any shares of our preferred stock. Our preferred stock and the rights of the holders of our preferred stock are subject to the applicable statutes of the State of Delaware, our Certificate of Incorporation, our Bylaws, as amended, and our Certificates of Designation.

General Terms

Our Board may, without further action by our stockholders, from time to time, direct the issuance of shares of preferred stock in series and may, at the time of issuance, determine the rights, preferences and limitations of each series, including voting rights, dividend rights and redemption and liquidation preferences. Satisfaction of any dividend preferences of outstanding shares of preferred stock would reduce the amount of funds available for the payment of dividends on shares of our common stock (although we do not anticipate paying any dividends to the holders of our common stock in the foreseeable future). Holders of shares of preferred stock may be entitled to receive a preference payment in the event of any liquidation, dissolution or winding-up of our Company before any payment is made to the holders of shares of our common stock. In some circumstances, the issuance of shares of preferred stock may render more difficult or tend to discourage a merger, tender offer or proxy contest, the assumption of control by a holder of a large block of our securities or the removal of incumbent management as discussed below. Upon the affirmative vote of our Board, without stockholder approval, we may issue shares of preferred stock with voting and conversion rights that could adversely affect the holders of shares of our common stock.

If we offer a specific series of preferred stock under this prospectus, we will describe the terms of the preferred stock in the prospectus supplement for such offering and will file a copy of the articles of amendment to the Articles establishing the terms of the preferred stock with the SEC. To the extent required, this description will include:

The preferred stock offered by this prospectus will, when issued, not have, or be subject to, any preemptive or similar rights.

Transfer Agent and Registrar

The transfer agent and registrar for our preferred stock in the United States will be Continental Stock Transfer & Trust Company.

DESCRIPTION OF DEBT SECURITIES

We may offer debt securities from time to time, as either senior or subordinated debt or as senior or subordinated convertible debt, in one or more offerings under this prospectus. We will issue any such debt securities under one or more separate indentures that we will enter into with a trustee to be named in the indenture and specified in the applicable prospectus supplement. The specific terms of debt securities being offered will be described in the applicable prospectus supplement. We have filed a form of indenture as an exhibit to the registration statement of which this prospectus forms a part.

The prospectus supplement relating to a particular issue of debt securities will describe the terms of those debt securities and the related indenture, which may include (without limitation) the following:

The indenture and the debt securities are expected to be governed by and construed in accordance with the laws of the State of New York. We intend to disclose the relevant restrictive covenants for any issuance or series of debt securities in the applicable prospectus supplement. Unless otherwise indicated in the applicable prospectus supplement, the debt securities will not be listed on any securities exchange. As of the date of this prospectus, we have no outstanding registered debt securities.

DESCRIPTION OF WARRANTS

We may issue warrants to purchase shares of our common stock, preferred stock, debt securities or other securities in one or more series together with other securities or separately, as described in the applicable prospectus supplement. Below is a description of certain general terms and provisions of the warrants that we may offer. Particular terms of the warrants will be described in the warrant agreements and the prospectus supplement to the warrants.

The applicable prospectus supplement will contain, where applicable, the following terms of and other information relating to the warrants:

Exercise of Warrants

Each warrant will entitle the holder to purchase for cash that principal amount of, or number of, securities, as the case may be, at the exercise price set forth in, or to be determined as set forth in, the applicable prospectus supplement relating to the warrants. After the close of business on the expiration date, unexercised warrants will become void. Upon receipt of payment and the warrant certificate properly completed and duly executed, we will, as soon as practicable, issue the securities purchasable upon exercise of the warrant. If less than all of the warrants represented by the warrant certificate are exercised, a new warrant certificate will be issued for the remaining amount of warrants.

No Rights of Security Holder Prior to Exercise

Before the exercise of their warrants, holders of warrants will not have any of the rights of holders of the securities purchasable upon the exercise of the warrants, and will not be entitled to:

Transfer Agent and Registrar

The transfer agent and registrar for any warrants will be set forth in the applicable prospectus supplement.

DESCRIPTION OF RIGHTS

As specified in the applicable prospectus supplement, we may issue rights to purchase the securities offered in this prospectus to our existing stockholders, and such rights may or may not be issued for consideration. The applicable prospectus supplement will describe the terms of any such rights. The description in the prospectus supplement will not purport to be complete and will be qualified in its entirety by reference to the documents pursuant to which such rights will be issued.

DESCRIPTION OF UNITS

This section outlines some of the provisions of the units and the unit agreements. This information may not be complete in all respects and is qualified entirely by reference to the unit agreement with respect to the units of any particular series. The specific terms of any series of units will be described in the applicable prospectus supplement. If so described in a particular supplement, the specific terms of any series of units may differ from the general description of terms presented below.

We may issue units comprised of shares of preferred stock, shares of common stock, warrants and debt securities in any combination. Each unit will be issued so that the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the rights and obligations of a holder of each included security. The unit agreement under which a unit is issued may provide that the securities included in the unit may not be held or transferred separately, at any time or at any time before a specified date.

The applicable prospectus supplement may describe:

The provisions described in this section, as well as those described under “Description of Preferred Stock,” “Description of Common Stock,” “Description of Warrants”, “Description of Debt Securities”, and “Description of Rights” will apply to the securities included in each unit, to the extent relevant.

Issuance in Series

We may issue units in such amounts and in as many distinct series as we wish. This section summarizes terms of the units that apply generally to all series. Most of the financial and other specific terms of any series will be described in the applicable prospectus supplement.

Unit Agreements

We will issue units under one or more unit agreements to be entered into between us and a bank or other financial institution, as unit agent. We may add, replace or terminate unit agents from time to time. We will identify the unit agreement under which each series of units will be issued and the unit agent under that agreement in the applicable prospectus supplement.

The following provisions will generally apply to all unit agreements unless otherwise stated in the applicable prospectus supplement.

Modification Without Consent.

We and the applicable unit agent may amend any unit or unit agreement without the consent of any holder to:

We do not need any approval to make changes that affect only units to be issued after the changes take effect. We may also make changes that do not adversely affect a particular unit in any material respect, even if they adversely affect other units in a material respect. In those cases, we do not need to obtain the approval of the holder of the unaffected unit; we need only obtain any required approvals from the holders of the affected units.

Modification With Consent.

We may not amend any particular unit or a unit agreement with respect to any particular unit unless we obtain the consent of the holder of that unit, if the amendment would:

Any other change to a particular unit agreement and the units issued under that agreement would require the following approval:

These provisions regarding changes with majority approval also apply to changes affecting any securities issued under a unit agreement, as the governing document.

In each case, the required approval must be given by written consent.

Unit Agreements Will Not Be Qualified Under Trust Indenture Act.

No unit agreement will be qualified as an indenture, and no unit agent will be required to qualify as a trustee, under the Trust Indenture Act. Therefore, holders of units issued under unit agreements will not have the protections of the Trust Indenture Act with respect to their units.

Mergers and Similar Transactions Permitted; No Restrictive Covenants or Events of Default.

The unit agreements will not restrict our ability to merge or consolidate with, or sell our assets to, another corporation or other entity or to engage in any other transactions. If at any time we merge or consolidate with, or sell our assets substantially as an entirety to, another corporation or other entity, the successor entity will succeed to and assume our obligations under the unit agreements. We will then be relieved of any further obligation under these agreements.

The unit agreements will not include any restrictions on our ability to put liens on our assets, including our interests in our subsidiaries, nor will they restrict our ability to sell our assets. The unit agreements also will not provide for any events of default or remedies upon the occurrence of any events of default.

Payments and Notices.

In making payments and giving notices with respect to our units, we will follow the procedures as described in the applicable prospectus supplement.

FORMS OF SECURITIES

General

Each of the securities issued under this prospectus will be represented either by a certificate issued in definitive form to a particular purchaser or by one or more global securities representing the entire issuance of securities. Unless the applicable prospectus supplement provides otherwise, certificated securities in definitive form and global securities will be issued in registered form. Definitive securities name you or your nominee as the owner of the security, and in order to transfer or exchange these securities or to receive payments other than interest or other interim payments, you or your nominee must physically deliver the securities to the trustee, registrar, paying agent or other agent, as applicable. Global securities name a depositary or its nominee as the owner of the debt securities, units or warrants represented by these global securities. The depositary maintains a computerized system that will reflect each purchaser’s beneficial ownership of the securities through an account maintained by the purchaser with its broker/dealer, bank, trust company or other representative, as we explain more fully below.

Registered Global (Book-Entry) Securities

We may issue the securities in the form of one or more fully registered global securities that will be deposited with a depositary or its nominee identified in the applicable prospectus supplement and registered in the name of that depositary or nominee. In those cases, one or more registered global securities will be issued in a denomination or aggregate denominations equal to the portion of the aggregate principal or face amount of the securities to be represented by registered global securities. Unless and until it is exchanged in whole for securities in definitive registered form, a registered global security may not be transferred except as a whole by and among the depositary for the registered global security, the nominees of the depositary or any successors of the depositary or those nominees.

If not described below, any specific terms of the depositary arrangement with respect to any securities to be represented by a registered global security will be described in the prospectus supplement relating to those securities. We anticipate that the following provisions will apply to all depositary arrangements.

Ownership of beneficial interests in a registered global security will be limited to persons, called participants, that have accounts with the depositary or persons that may hold interests through participants. Upon the issuance of a registered global security, the depositary will credit, on its book-entry registration and transfer system, the participants’ accounts with the respective principal or face amounts of the securities beneficially owned by the participants. Any dealers, underwriters or agents participating in the distribution of the securities will designate the accounts to be credited. Ownership of beneficial interests in a registered global security will be shown on, and the transfer of ownership interests will be effected only through, records maintained by the depositary, with respect to interests of participants, and on the records of participants, with respect to interests of persons holding through participants. The laws of some states may require that some purchasers of securities take physical delivery of these securities in definitive form. These laws may impair such purchasers’ abilities to own, transfer or pledge beneficial interests in registered global securities.

So long as the depositary, or its nominee, is the registered owner of a registered global security, that depositary or its nominee, as the case may be, will be considered the sole owner or holder of the securities represented by the registered global security for all purposes under the applicable indenture, unit agreement or warrant agreement. Except as described below, owners of beneficial interests in a registered global security will not be entitled to have the securities represented by the registered global security registered in their names, will not receive or be entitled to receive physical delivery of the securities in definitive form and will not be considered the owners or holders of the securities under the applicable indenture, unit agreement or warrant agreement. Accordingly, each person owning a beneficial interest in a registered global security must rely on the procedures of the depositary for that registered global security and, if that person is not a participant, on the procedures of the participant through which the person owns its interest, to exercise any rights of a holder under the applicable indenture, unit agreement or warrant agreement. We understand that under existing industry practices, if we request any action of holders or if an owner of a beneficial interest in a registered global security desires to give or take any action that a holder is entitled to give or take under the applicable indenture, unit agreement or warrant agreement, the depositary for the registered global security would authorize the participants holding the relevant beneficial interests to give or take that action, and the participants would authorize beneficial owners owning through them to give or take that action or would otherwise act upon the instructions of beneficial owners holding through them.

Principal, premium, if any, on and interest payments on debt securities, and any payments to holders with respect to warrants or units represented by a registered global security registered in the name of a depositary or its nominee will be made to the depositary or its nominee, as the case may be, as the registered owner of the registered global security. None of us, the trustees, the warrant agents, the unit agents or any other agent of ours, agent of the trustees or agent of the warrant agents or unit agents will have any responsibility or liability for any aspect of the records relating to payments made on account of beneficial ownership interests in the registered global security or for maintaining, supervising or reviewing any records relating to those beneficial ownership interests.

We expect that the depositary for any of the securities represented by a registered global security, upon receipt of any payment of principal, premium, interest or other distribution of underlying securities or other property to holders on that registered global security, will immediately credit participants’ accounts in amounts proportionate to their respective beneficial interests in that registered global security as shown on the records of the depositary. We also expect that payments by participants to owners of beneficial interests in a registered global security held through participants will be governed by standing customer instructions and customary practices, as is now the case with the securities held for the accounts of customers or registered in “street name,” and will be the responsibility of those participants.

If the depositary for any of the securities represented by a registered global security is at any time unwilling or unable to continue as depositary or ceases to be a clearing agency registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and a successor depositary registered as a clearing agency under the Exchange Act is not appointed by us within 90 days, we will issue securities in definitive form in exchange for the registered global security that had been held by the depositary. Any securities issued in definitive form in exchange for a registered global security will be registered in the name or names that the depositary gives to the relevant trustee, warrant agent, unit agent or other relevant agent of ours or theirs. It is expected that the depositary’s instructions will be based upon directions received by the depositary from participants with respect to ownership of beneficial interests in the registered global security that had been held by the depositary.

PLAN OF DISTRIBUTION

We may sell the securities in any one or more of the following methods from time to time:

The distribution of the securities may be effected from time to time in one or more transactions:

Any of the prices may represent a discount from the prevailing market prices.

Any underwritten offering may be on a best efforts or a firm commitment basis. If underwriters are used in the sale, the securities acquired by the underwriters will be for their own account. The underwriters may resell the securities in one or more transactions, including without limitation negotiated transactions, at a fixed public offering price or at a varying price determined at the time of sale. The obligations, if any, of the underwriter to purchase any securities will be subject to certain conditions. We may offer the securities to the public through underwriting syndicates represented by managing underwriters or by underwriters without a syndicate. Subject to certain conditions, the underwriters will be obligated to purchase all of the securities if any are purchased, other than securities covered by any over-allotment option. Any public offering price and any discounts or concessions allowed, reallowed or paid to dealers may be changed from time to time.

If a dealer is used in an offering of securities, we may sell the securities to the dealer, as principal. The dealer may then resell the securities to the public at varying prices to be determined by the dealer at the time of sale.

We may sell securities directly or through agents we designate from time to time. We will name any agent involved in the offering and sale of securities and we will describe any commissions we will pay the agent in the prospectus supplement. Unless the prospectus supplement states otherwise, our agent will act on a best-efforts basis for the period of its appointment.

We may also sell securities directly to one or more purchasers without using underwriters, dealers or agents.

We may also make direct sales through subscription rights distributed to our stockholders on a pro rata basis, which may or may not be transferable. In any distribution of subscription rights to stockholders, if all of the underlying securities are not subscribed for, we may then sell the unsubscribed securities directly to third parties or may engage the services of one or more underwriters, dealers or agents, including standby underwriters, to sell the unsubscribed securities to third parties.

From time to time, we may offer securities directly to the public, with or without the involvement of agents, underwriters or dealers, and may use the Internet or another electronic bidding or ordering system for the pricing and allocation of the securities. Such a system may allow bidders to participate directly, through electronic access to an auction site, by submitting conditional offers to buy that are subject to acceptance by us and may directly affect the price or other terms at which such securities are sold. Such a bidding or ordering system may present to each bidder, on a real-time basis, relevant information to assist you in making a bid, such as the clearing spread at which the offering would be sold, based on the bids submitted, and whether a bidder’s individual bids would be accepted, pro-rated or rejected. Other pricing methods also may be used. Upon completion of such an auction process, securities will be allocated based on prices bid, terms of bid or other factors. The final offering price at which securities would be sold and the allocation of securities among bidders would be based in whole or in part on the results of the Internet bidding process or auction. Many variations of the Internet auction or pricing and allocation systems are likely to be developed in the future, and we may use such systems in connection with the sale of securities. The specific rules of such an auction would be distributed to potential bidders in an applicable prospectus supplement. If an offering is made using such a bidding or ordering system you should review the auction rules, as described in the prospectus supplement, for a more detailed description of the offering procedures.

In the sale of the securities, underwriters, dealers or agents may receive compensation from us or from purchasers of the securities, for whom they may act as agents, in the form of discounts, concessions or commissions. Underwriters may sell the securities to or through dealers, and such dealers may receive compensation in the form of discounts, concessions or commissions from the underwriters and/or commissions from the purchasers for whom they may act as agents. Underwriters, dealers and agents that participate in the distribution of the securities may be deemed to be underwriters under the Securities Act and any discounts or commissions they receive from us and any profit on the resale of securities they realize may be deemed to be underwriting discounts and commissions under the Securities Act. The applicable prospectus supplement will, where applicable:

Unless otherwise specified in the related prospectus supplement, each series of securities will be a new issue with no established trading market, other than the common stock, which is listed on the Nasdaq Capital Market. Any common stock sold pursuant to a prospectus supplement will be listed on the Nasdaq Capital Market, subject to applicable notices. We may elect to apply for quotation or listing of any other class or series of our securities, on a quotation system or an exchange but we are not obligated to do so. It is possible that one or more underwriters may make a market in a class or series of our securities, but such underwriters will not be obligated to do so and may discontinue any market making at any time without notice. Therefore, no assurance can be given as to the liquidity of, or the trading market for, any other class or series of our securities.

In connection with an offering, an underwriter may purchase and sell securities in the open market. These transactions may include short sales, stabilizing transactions and purchases to cover positions created by short sales. Short sales involve the sale by the underwriters of a greater number of securities than they are required to purchase in the offering. “Covered” short sales are sales made in an amount not greater than the underwriters’ option to purchase additional securities, if any, from us in the offering. If the underwriters have an over-allotment option to purchase additional securities from us, the underwriters may close out any covered short position by either exercising their over-allotment option or purchasing securities in the open market. In determining the source of securities to close out the covered short position, the underwriters may consider, among other things, the price of securities available for purchase in the open market as compared to the price at which they may purchase securities through the over-allotment option. “Naked” short sales are any sales in excess of such option or where the underwriters do not have an over-allotment option. The underwriters must close out any naked short position by purchasing securities in the open market. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of the securities in the open market after pricing that could adversely affect investors who purchase in the offering.

Accordingly, to cover these short sales positions or to otherwise stabilize or maintain the price of the securities, the underwriters may bid for or purchase securities in the open market and may impose penalty bids. If penalty bids are imposed, selling concessions allowed to syndicate members or other broker-dealers participating in the offering are reclaimed if securities previously distributed in the offering are repurchased, whether in connection with stabilization transactions or otherwise. The effect of these transactions may be to stabilize or maintain the market price of the securities at a level above that which might otherwise prevail in the open market. The impositions of a penalty bid may also affect the price of the securities to the extent that it discourages resale of the securities. The magnitude or effect of any stabilization or other transactions is uncertain. These transactions may be effected on the NYSE American or otherwise and, if commenced, may be discontinued at any time.

We do not make any representation or prediction as to the direction or magnitude of any effect that the transactions described above might have on the price of the securities. In addition, we do not make any representation that underwriters will engage in such transactions or that such transactions, once commenced, will not be discontinued without notice at any time.

Under agreements into which we may enter, underwriters, dealers and agents who participate in the distribution of the securities may be entitled to indemnification by us against certain civil liabilities, including liabilities under the Securities Act, or contribution from us to payments which the underwriters, dealers or agents may be required to make.

Underwriters, dealers and agents may engage in transactions with us or perform services for us in the ordinary course of business.

If indicated in the applicable prospectus supplement, securities may also be offered or sold by a “remarketing firm” in connection with a remarketing arrangement contemplated by the terms of the securities. Remarketing firms may act as principals for their own accounts or as agents. The applicable prospectus supplement will identify any remarketing firm and the terms of its agreement, if any, with us. It will also describe the remarketing firm’s compensation. Remarketing firms may be deemed to be underwriters in connection with the remarketing of the securities.

If indicated in the applicable prospectus supplement, we will authorize underwriters, dealers or other persons acting as our agents to solicit offers by particular institutions to purchase securities from us at the public offering price set forth in such prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery on such future date or dates stated in such prospectus supplement. Each delayed delivery contract will be for an amount no less than, and the aggregate principal amounts of securities sold under delayed delivery contracts shall be not less nor more than, the respective amounts stated in the applicable prospectus supplement. Institutions with which such delayed delivery contracts, when authorized, may be made include commercial and savings banks, insurance companies, pension funds, investment companies, educational and charitable institutions and others, but will in all cases be subject to our approval. The obligations of any purchaser under any such contract will be subject to the conditions that (1) the purchase of the securities shall not at the time of delivery be prohibited under the laws of any jurisdiction in the United States to which the purchaser is subject, and (2) if the securities are being sold to underwriters, we shall have sold to the underwriters the total principal amount of the securities less the principal amount thereof covered by the delayed delivery contracts. The underwriters and such other agents will not have any responsibility in respect of the validity or performance of such delayed delivery contracts.

With respect to the sale of any securities under this prospectus, the maximum compensation to be received by any member of the Financial Industry Regulatory Authority, Inc. or independent broker or dealer is not expected to be greater than eight percent (8%).

To comply with applicable state securities laws, the securities offered by this prospectus will be sold, if necessary, in such jurisdictions only through registered or licensed brokers or dealers. In addition, securities may not be sold in some states unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with.

CERTAIN PROVISIONS OF DELAWARE LAW AND OF OUR

CERTIFICATE OF INCORPORATION AND BYLAWS

Anti-Takeover Provisions of our Certificate of Incorporation and Bylaws

In addition to the board of directors’ ability to issue shares of preferred stock, our Certificate of Incorporation and our Bylaws contain other provisions that are intended to enhance the likelihood of continuity and stability in the composition of the board of directors and which may have the effect of delaying, deferring or preventing a future takeover or change in control of our company unless such takeover or change in control is approved by our board of directors. These provisions include our classified board of directors as discussed above in “Description of Common Stock – Our Board of Directors” and advance notice procedures for stockholder proposals.

Classified Board.

The provision for a classified board could prevent a party who acquires control of a majority of our outstanding common stock from obtaining control of the board until our second annual stockholders meeting following the date the acquirer obtains the controlling stock interest. The classified board provision could have the effect of discouraging a potential acquirer from making a tender offer or otherwise attempting to obtain control of us and could increase the likelihood that incumbent directors will retain their positions.

Size of Board and Vacancies.

Our Certificate of Incorporation provides that the total number of directors constituting our board of directors be fixed from time to time exclusively by resolution adopted by a majority of the directors then in office, although less than a quorum (as defined in our Bylaws, as amended), or by the sole remaining director. Subject to the special rights of the holders of any series of preferred stock to elect directors, directors are elected at each annual meeting of stockholders by the vote of a majority of the shares present. Subject to the special rights of the holders of any series of preferred stock, directors can only be removed for cause by the affirmative vote of the holders of at least two-thirds of the voting power of the then-outstanding shares of the Company’s capital stock of the Corporation entitled to vote generally in the election of directors voting together as a single class.

Elimination of Stockholder Action by Written Consent.

Our Certificate of Incorporation eliminates the right of our stockholders to act by written consent. Stockholder action must take place at the annual or a special meeting of our stockholders.

Advance Notice Procedures for Stockholder Proposals.

Our Bylaws establish an advance notice procedure for stockholder proposals to be brought before an annual meeting of our stockholders, including proposed nominations of persons for election to our board. Stockholders at our annual meeting may only consider proposals or nominations specified in the notice of meeting or brought before the meeting by or at the direction of our board or by a stockholder who was a stockholder of record on the record date for the meeting, who is entitled to vote at the meeting and who has given to our secretary timely written notice, in proper form, of the stockholder’s intention to bring that business before the meeting. Although our Bylaws do not give our board the power to approve or disapprove stockholder nominations of candidates or proposals regarding other business to be conducted at a special or annual meeting, our Bylaws may have the effect of precluding the conduct of some business at a meeting if the proper procedures are not followed or may discourage or defer a potential acquirer from conducting a solicitation of proxies to elect its own slate of directors or otherwise attempting to obtain control of us.

Special Meetings of Stockholders.

Our Certificate of Incorporation provides that special meetings of our stockholders may only be called by the Chairperson of our Board, our Chief Executive Officer or our Board acting pursuant to a resolution adopted by a majority of the directors then in office, and may not be called by any other person or persons. Only the business stated in the notice for a special meeting will be considered at the special meeting of stockholders.

Anti-Takeover Effects of Delaware Law

Section 203.

We are subject to the provisions of Section 203 of the Delaware General Corporation Law (the “DGCL”). Under Section 203, we would generally be prohibited from engaging in any business combination with any interested stockholder for a period of three years following the time that the stockholder became an interested stockholder unless:

Under Section 203, a “business combination” includes:

In general, Section 203 defines an interested stockholder as an entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by such entity or person.

No Cumulative Voting.

Delaware law prohibits cumulative voting for the election of a corporation’s directors unless the corporation’s certificate of incorporation authorizes cumulative voting. Our Certificate of Incorporation does not provide for cumulative voting in the election of directors. Cumulative voting would allow a minority stockholder to vote a portion or all of its shares for one or more candidates for seats on our board of directors. Without cumulative voting, a minority stockholder will not be able to gain as many seats on our board of directors based on the number of shares of our stock the stockholder holds as compared to the number of seats the stockholder would be able to gain if cumulative voting were permitted. The absence of cumulative voting under our Certificate of Incorporation makes it more difficult for a minority stockholder to gain a seat on our board of directors to influence our board’s decision regarding a takeover.

Amendments to Our Governance Documents.

Delaware law generally provides that the affirmative vote of a majority of the shares entitled to vote on a matter is required to amend a corporation’s certificate of incorporation or bylaws, unless the corporation’s certificate of incorporation or bylaws requires a greater percentage.

Our Bylaws permit our board of directors to adopt, amend or repeal our Bylaws with the approval of a majority of the directors then in office; provided, however, that the amendment or repeal of Section 2.6 of our Bylaws requires the approval of at least two-thirds of the directors then in office. The stockholders also have the power to adopt, amend or repeal our Bylaws; provided, however, that the affirmative vote of the holders of at least two-thirds of the voting power of all of the then-outstanding shares of our capital stock entitled to vote generally in the election of directors, voting together as a single class, is required to adopt, amend or repeal any provision of our Bylaws; and provided, further, that if two-thirds of the directors then in office have approved such adoption, amendment or repeal of any provisions of our Bylaws, then only the affirmative vote of the holders of at least a majority of the voting power of all of the then-outstanding shares of our capital stock entitled to vote generally in the election of directors, voting together as a single class, will be required to adopt, amend or repeal any provision of our Bylaws.

Our Certificate of Incorporation provides that, in addition to any vote of the holders of any class or series of our stock that may be required by law or our Certificate of Incorporation or any Certificate of Designation, the affirmative vote of the holders of at least two-thirds of the voting power of all of the then-outstanding shares of our capital stock entitled to vote generally in the election of directors, voting together as a single class, will be required to amend or repeal or adopt any provision inconsistent with Sections 1.2 and 3.1 of Article IV, or Article V, Article VII, Article VIII, Article IX, Article X or Article XI (the “Specified Provisions”); provided, further, that if two-thirds of the directors then in office have approved such amendment or repeal of, or any provision inconsistent with, the Specified Provisions, then only the affirmative vote of the holders of at least a majority of the voting power of all of the then-outstanding shares of our capital stock entitled to vote generally in the election of directors, voting together as a single class, will be required to amend or repeal, or adopt any provision inconsistent with, the Specified Provisions.

The stockholder vote with respect to an amendment of our Certificate of Incorporation or Bylaws would be in addition to any separate class vote that might in the future be required under the terms of any series of preferred stock that might be outstanding at the time such a proposed amendment were submitted to stockholders.

Limitations on Liability and Indemnification of Officers and Directors

Our Certificate of Incorporation limits Jet.AI’s directors’ liability to the fullest extent permitted under the DGCL. The DGCL provides that directors of a corporation will not be personally liable for monetary damages for breach of their fiduciary duties as directors, except for liability:

如果DGCL被修改以授權進一步消除或限制董事的個人責任，Jet.AI董事的責任將被消除或限制到DGCL允許的最大程度，如經修改。

根據我們的章程規定，在特拉華法律允許的範圍內，我們將爲因爲董事或董事在我們的請求下作爲任何其他實體的董事或董事服務而發起的訴訟，提供賠償並墊付董事或董事合理發生或遭受的所有費用、責任和損失。根據我們的章程，我們可以購買並維護保險，以保護公司及公司的董事、董事、僱員或代理人或其他公司、合夥企業、合資企業、信託或其他企業的費用、責任或損失，無論我們是否有權根據DGCL規定對這些費用、責任或損失進行賠償。

在此範圍內，如因上述規定而對公司的董事、高級職員或控股人因證券法產生的責任進行賠償，公司已被告知，根據證券法規定，此種賠償是違反公共政策的，因此是不可執行的。如果公司的任何董事、高級職員或控股人在有關注冊證券的事宜中提出要求賠償（除了由公司支付在任何訴訟中已由公司的董事、高級職員或公司的控股人支付的費用之外），則公司將依法律顧問的意見，提交給適當管轄區域的法院，對公司所述賠款是否違反證券法的公共政策問題進行最終裁決。

包含參考的資料

證監會允許我們通過參照我們向其提交的信息和報告來進行合併，這意味着我們可以通過引用這些文件向您披露重要信息。我們的證監會文件編號是001-40725。參考合併的信息是本招股說明書的重要組成部分，我們稍後向證監會提交的信息將自動更新並取代已經參考合併的信息。我們正在參考合併以下列在證監會已經提交的文件，以及我們根據《證券交易法》第13(a)、13(c)、14或15(d)條在未來向證監會提交的文件，除非將所有證券賣出之前，未來報告或文件的任何部分沒有根據這些規定被視爲已提交。

根據書面或口頭要求，我們將免費向每個人提供此招股說明書副本，包括任何受益所有人，並提供已納入本招股說明書的文件的副本。 您可以通過書面或致電以下地址向我們索取這些申報文件和我們在本招股說明書中明確納入爲展品的任何展品，而不產生任何費用：

Jet.AI公司

公司秘書提供

10845 Griffith Peak Dr.

200套房間

Las Vegas，NV 89135

(702) 747-4000

本招股說明書是我們向美國證券交易委員會提交的登記聲明的一部分。我們已將展覽文件合併到此登記聲明中。 您應該仔細閱讀展覽文件，以了解對您可能重要的條款。

您應該僅依賴通過引用或本招股說明書或任何招股說明書補充提供的信息。我們並未授權任何人向您提供其他信息。我們不在任何未允許該要約的州提供這些證券的要約。您不應假設本招股說明書或引用的文件中的信息截至除了本招股說明書或這些文件正面的日期外的任何日期都是準確的。

您可以在何處獲取更多信息

我們需遵守《證券交易法》的信息披露要求，並依照《證券交易法》，向美國證券交易委員會提交年度、季度和其他各類報告、代理聲明以及其他信息。您可在SEC的公共參考室（地址：100 F Street, N.E., Washington, D.C. 20549）查閱和複印我們提交的任何文件。您可致電1-800-SEC-0330與SEC聯繫，了解公共參考室的操作。這些文件也可通過SEC的電子數據收集、分析和檢索系統，即EDGAR，通過電子方式獲取，包括通過SEC在互聯網上的主頁（www.sec.gov）。

我們有權限指定併發行不止一類或系列的股票，具有各種優先權、轉換和其他權利、投票權、限制、分紅派息限制、資格和贖回條件。請參閱「優先股描述」和「普通股描述」。在請求時，我們將免費提供已指定的每一類或系列股票的相對權利和偏好以及對任何股東擁有或轉讓我們的股票的任何限制的完整說明。有關這些副本的書面要求應直接寄往Jet.AI 公司，收件人：公司秘書，10845 Griffith Peak Dr., Suite 200, 拉斯維加斯，內華達州 89135。我們的電話號碼是 (702) 747-4000。我們的網站位於 www.Jet.AI。我們網站上包含的信息不被視爲本招股說明書的參考資料，因此不屬於本招股說明書或任何附屬招股說明書的一部分。

可獲取更多信息的地方

黑客 Johnson & Smith會計師事務所作爲獨立註冊的上市會計師事務所，已經審計了我們公司截至2023年和2022年12月31日的年度報告中包含的基本報表，隨附在他們的報告中，並在本招股說明書和註冊聲明的其他地方引用。我們的基本報表是依賴於引用合併記載的。 黑客 Johnson & Smith會計師事務所 作爲會計和審計方面的專家，依其權威所作的報告。

法律事項。

某些法律事宜，包括所提供證券的合法性，將由Dykema Gossett PLLC事務所代表我們處理。